0001648903false--12-31FY20210.0011000000002699833822367179200000000.001111157700549999990.00135499947333230000000.0016600006600006600001650000P36M600002240000.121479910000048997500000.210P0Y000000044700000000.680.200.21P2Y3D315001000000.21354400P2Y3D00071950001222000203659730000.800016489032021-01-012021-12-310001648903us-gaap:SubsequentEventMember2022-01-012022-01-040001648903us-gaap:SubsequentEventMember2022-02-012022-02-040001648903us-gaap:SubsequentEventMember2022-02-040001648903us-gaap:SubsequentEventMember2022-03-012022-03-230001648903srt:MaximumMember2021-12-310001648903fifg:VendorTwoMemberfifg:PurchaseCommitmentsMember2020-01-012020-12-310001648903fifg:VendorOneMemberfifg:PurchaseCommitmentsMember2021-01-012021-12-310001648903fifg:VendorOneMemberfifg:PurchaseCommitmentsMember2020-01-012020-12-310001648903fifg:CustomerOneMember2021-01-012021-12-310001648903fifg:MerchantOneMember2021-01-012021-12-310001648903fifg:CustomerTwoMember2021-01-012021-12-310001648903fifg:MerchantTwoMember2020-01-012020-12-310001648903fifg:MerchantOneMember2020-01-012020-12-310001648903fifg:CustomerThreeMember2021-01-012021-12-310001648903fifg:StageThreeMemberfifg:CFNMediaMember2019-08-012019-08-140001648903fifg:StageTwoMemberfifg:CFNMediaMember2019-08-012019-08-140001648903fifg:StageOneMemberfifg:CFNMediaMember2019-08-012019-08-140001648903fifg:ConsultantMember2021-07-012021-07-130001648903fifg:ConsultantMember2021-07-130001648903fifg:ConsultingAgreementTwoMember2020-11-012020-11-0900016489032018-06-152018-07-160001648903fifg:ConsultingAgreementMember2018-06-152018-07-1600016489032020-10-012020-10-150001648903fifg:OperatingLeasesMember2020-01-012020-12-310001648903fifg:OperatingLeasesMember2021-01-012021-12-3100016489032020-06-012020-06-2300016489032020-06-2300016489032020-05-222020-06-230001648903fifg:PromissoryNoteTwoMember2020-01-290001648903fifg:PromissoryNoteTwoMember2020-01-012020-01-290001648903fifg:BlackScholesModelMember2020-07-012020-07-070001648903fifg:MrKaplansMemberfifg:ConsultingAgreementMember2020-01-012020-12-310001648903fifg:MrKaplansMemberfifg:ConsultingAgreementMember2021-01-012021-12-310001648903fifg:MrKaplansMemberfifg:ConsultingAgreementMember2021-08-040001648903fifg:MrKaplansMemberfifg:ConsultingAgreementMember2020-07-070001648903fifg:MrKaplansMemberfifg:ConsultingAgreementMember2021-08-012021-08-040001648903fifg:MrKaplansMemberfifg:ConsultingAgreementMember2020-07-012020-07-070001648903fifg:CFOandDirectorMemberus-gaap:SeriesBPreferredStockMember2020-01-012020-12-310001648903fifg:CFOandDirectorMemberus-gaap:SeriesBPreferredStockMember2021-05-012021-05-100001648903fifg:CFOandDirectorMemberus-gaap:SeriesBPreferredStockMember2021-06-012021-06-300001648903fifg:CFOandDirectorMemberus-gaap:SeriesBPreferredStockMember2021-08-012021-08-060001648903fifg:CFOandDirectorMemberus-gaap:SeriesBPreferredStockMember2021-08-012021-08-040001648903fifg:CFOandDirectorMemberus-gaap:SeriesBPreferredStockMember2021-09-012021-09-200001648903fifg:CFOandDirectorMemberus-gaap:SeriesBPreferredStockMember2021-10-012021-10-280001648903fifg:CFOandDirectorMemberus-gaap:SeriesBPreferredStockMember2021-10-012021-10-250001648903fifg:CFOandDirectorMemberus-gaap:SeriesBPreferredStockMember2020-11-012020-11-090001648903fifg:CFOandDirectorMemberus-gaap:SeriesBPreferredStockMember2020-03-180001648903fifg:CFOandDirectorMemberus-gaap:SeriesBPreferredStockMember2020-07-310001648903fifg:CFOandDirectorMemberus-gaap:SeriesBPreferredStockMember2020-08-040001648903fifg:CFOandDirectorMemberus-gaap:SeriesBPreferredStockMember2021-05-100001648903fifg:CFOandDirectorMemberus-gaap:SeriesBPreferredStockMember2021-06-290001648903fifg:CFOandDirectorMemberus-gaap:SeriesBPreferredStockMember2021-06-300001648903fifg:CFOandDirectorMemberus-gaap:SeriesBPreferredStockMember2021-08-040001648903fifg:CFOandDirectorMemberus-gaap:SeriesBPreferredStockMember2021-08-060001648903fifg:CFOandDirectorMemberus-gaap:SeriesBPreferredStockMember2021-09-200001648903fifg:CFOandDirectorMemberus-gaap:SeriesBPreferredStockMember2021-10-250001648903fifg:CFOandDirectorMemberus-gaap:SeriesBPreferredStockMember2021-10-280001648903fifg:AugustFourTwoThousandTwentyMemberfifg:EmploymentAgreementMember2020-01-012020-12-310001648903fifg:AugustFourTwoThousandTwentyMemberfifg:EmploymentAgreementMember2021-01-012021-12-310001648903fifg:MichaelKaplanMember2020-08-012020-08-040001648903fifg:MichaelKaplanMember2020-07-012020-07-070001648903fifg:MichaelKaplanMember2020-08-040001648903fifg:MichaelKaplanMember2020-07-070001648903fifg:MichaelKaplanMember2020-01-012020-12-310001648903fifg:MichaelKaplanMember2021-01-012021-12-310001648903fifg:ConsultantMember2020-07-052020-07-310001648903us-gaap:SeriesBPreferredStockMember2021-05-100001648903us-gaap:SeriesBPreferredStockMember2020-01-012020-12-310001648903us-gaap:SeriesBPreferredStockMember2021-01-012021-12-3100016489032020-11-012020-11-0900016489032021-06-2900016489032020-08-070001648903fifg:WarrantsMemberus-gaap:SeriesAPreferredStockMember2021-12-310001648903fifg:SeriesAConvertiblePreferredStockMember2020-01-012020-12-310001648903fifg:WarrantsMemberus-gaap:SeriesAPreferredStockMember2021-01-012021-12-310001648903fifg:WarrantsMemberus-gaap:SeriesAPreferredStockMember2020-01-012020-12-310001648903fifg:WeightedAverageExercisePriceMember2020-01-012020-12-310001648903fifg:WeightedAverageExercisePriceMember2021-01-012021-12-310001648903fifg:WarrantsMember2020-01-012020-12-310001648903fifg:WarrantsMember2021-01-012021-12-310001648903srt:MaximumMember2020-01-012020-12-310001648903srt:MinimumMember2020-01-012020-12-310001648903srt:MaximumMember2021-01-012021-12-310001648903srt:MinimumMember2021-01-012021-12-310001648903fifg:MilestoneEventSixMember2021-01-012021-12-310001648903fifg:MilestoneEventFiveMember2021-01-012021-12-310001648903fifg:MilestoneEventFourMember2021-01-012021-12-310001648903fifg:MilestoneEventThreeMember2021-01-012021-12-310001648903fifg:MilestoneEventTwoMember2021-01-012021-12-310001648903fifg:MilestoneEventOneMember2021-01-012021-12-310001648903fifg:MilestoneEventSixMember2021-12-310001648903fifg:MilestoneEventFiveMember2021-12-310001648903fifg:MilestoneEventFourMember2021-12-310001648903fifg:MilestoneEventThreeMembersrt:MaximumMember2021-12-310001648903fifg:MilestoneEventThreeMembersrt:MinimumMember2021-12-310001648903fifg:MilestoneEventTwoMember2021-12-310001648903fifg:MilestoneEventOneMember2021-12-310001648903fifg:PromissoryNoteTenMember2021-01-012021-12-310001648903fifg:PromissoryNoteSixMember2021-01-012021-12-310001648903fifg:PromissoryNoteFiveMember2021-01-012021-12-310001648903fifg:PromissoryNoteTwoMember2021-01-012021-12-310001648903fifg:PromissoryNoteFourMember2021-01-012021-12-310001648903fifg:PromissoryNoteThreeMember2021-01-012021-12-310001648903fifg:PromissoryNoteEightMember2021-01-012021-12-310001648903fifg:PromissoryNoteSevenMember2021-01-012021-12-310001648903fifg:PromissoryNoteNineMember2021-01-012021-12-310001648903fifg:PromissoryNoteOneMember2021-01-012021-12-310001648903fifg:ConvertibleNotePayableMember2021-01-012021-12-310001648903fifg:PromissoryNoteElevenMember2021-01-012021-12-310001648903fifg:EconomicInjuryDisasterMember2021-01-012021-12-310001648903fifg:EconomicInjuryDisasterMember2020-12-310001648903fifg:EconomicInjuryDisasterMember2021-12-310001648903fifg:AugustFourTwoThousandTwentyOneMember2020-01-012020-12-310001648903fifg:AugustFourTwoThousandTwentyOneMember2021-01-012021-12-3100016489032021-10-012021-10-140001648903fifg:AprilThirtyOneTwoThousandTwentyTwoMember2021-10-012021-10-2800016489032021-10-012021-10-280001648903fifg:MarchSixteenTwoThousandTwentyTwoMember2021-08-012021-08-0400016489032021-09-012021-09-200001648903fifg:JulyTwentyNineTwoThousandTwentyTwoMember2021-10-280001648903fifg:AprilThirtyOneTwoThousandTwentyTwoMember2021-10-2800016489032021-10-2800016489032021-08-0600016489032021-08-040001648903fifg:AprilThirtyOneTwoThousandTwentyTwoMember2021-06-1900016489032021-12-012021-12-0200016489032021-10-012021-10-0800016489032021-08-012021-08-0600016489032021-06-012021-06-190001648903fifg:MarchTwentyOneTwoThousandTwentyTwoMember2021-08-012021-08-0600016489032021-08-012021-08-040001648903fifg:PromissoryNoteSevenTeenMember2021-12-310001648903fifg:PromissoryNoteSixTeenMember2021-12-310001648903fifg:PromissoryNoteFifTeenMember2020-12-310001648903fifg:PromissoryNoteFifTeenMember2021-12-310001648903fifg:PromissoryNoteFourteenMember2020-12-310001648903fifg:PromissoryNoteFourteenMember2021-12-310001648903fifg:PromissoryNoteThirteenMember2020-12-310001648903fifg:PromissoryNoteThirteenMember2021-12-310001648903fifg:PromissoryNoteTwelveMember2020-12-310001648903fifg:PromissoryNoteTwelveMember2021-12-310001648903fifg:PromissoryNoteElevenMember2020-12-310001648903fifg:PromissoryNoteElevenMember2021-12-310001648903fifg:PromissoryNoteTenMember2020-12-310001648903fifg:PromissoryNoteTenMember2021-12-310001648903fifg:PromissoryNoteNineMember2020-12-310001648903fifg:PromissoryNoteNineMember2021-12-310001648903fifg:PromissoryNoteEightMember2020-12-310001648903fifg:PromissoryNoteEightMember2021-12-310001648903fifg:PromissoryNoteSevenMember2020-12-310001648903fifg:PromissoryNoteSevenMember2021-12-310001648903fifg:PromissoryNoteSixMember2020-12-310001648903fifg:PromissoryNoteSixMember2021-12-310001648903fifg:PromissoryNoteFiveMember2020-12-310001648903fifg:PromissoryNoteFiveMember2021-12-310001648903fifg:PromissoryNoteFourMember2020-12-310001648903fifg:PromissoryNoteFourMember2021-12-310001648903fifg:PromissoryNoteThreeMember2020-12-310001648903fifg:PromissoryNoteThreeMember2021-12-310001648903fifg:PromissoryNoteTwoMember2020-12-310001648903fifg:PromissoryNoteTwoMember2021-12-310001648903fifg:PromissoryNoteOneMember2020-12-310001648903fifg:PromissoryNoteOneMember2021-12-310001648903fifg:ConvertibleNotePayableMember2020-12-310001648903fifg:ConvertibleNotePayableMember2021-12-310001648903fifg:PromissoryNoteSevenTeenMember2020-12-310001648903fifg:PromissoryNoteSixTeenMember2020-12-310001648903us-gaap:AccountsPayableAndAccruedLiabilitiesMember2020-12-310001648903us-gaap:AccountsPayableAndAccruedLiabilitiesMember2021-12-310001648903fifg:EmploymentAgreementMemberfifg:MrKestenbaumMember2020-12-310001648903fifg:EmploymentAgreementMemberfifg:MrKestenbaumMember2017-02-270001648903fifg:EmploymentAgreementMemberfifg:MrKestenbaumMember2021-12-310001648903srt:MaximumMemberfifg:DirectorAgreementsMember2018-05-100001648903srt:MinimumMemberfifg:DirectorAgreementsMember2018-05-100001648903srt:MinimumMemberfifg:DirectorAgreementsMember2021-12-310001648903srt:MaximumMemberfifg:DirectorAgreementsMember2021-12-310001648903fifg:JulySevenTwoThousandTwentyMemberfifg:MrKaplanMember2021-01-012021-12-310001648903fifg:WarrantsMemberus-gaap:SeriesBPreferredStockMember2020-01-012020-12-310001648903fifg:ConsultantMember2021-05-012021-05-100001648903fifg:DirectorAgreementsMember2020-12-310001648903fifg:DirectorAgreementsMember2021-12-310001648903fifg:MarchFirstTwoThousandSeventeenMemberfifg:EmploymentAgreementMemberfifg:MrKeeleyMember2020-07-012020-07-070001648903fifg:PreferredBStockMember2021-01-012021-12-310001648903fifg:WarrantsMemberus-gaap:SeriesBPreferredStockMember2021-01-012021-12-310001648903srt:MaximumMemberfifg:DirectorAgreementsMember2021-01-012021-12-310001648903srt:MinimumMemberfifg:DirectorAgreementsMember2021-01-012021-12-3100016489032021-05-012021-05-100001648903fifg:ConsultantMember2021-01-012021-12-310001648903fifg:ConsultantMember2020-01-012020-12-310001648903fifg:DirectorAgreementsMember2020-01-012020-01-300001648903fifg:MarchFirstTwoThousandSeventeenMemberfifg:EmploymentAgreementMemberfifg:MrKeeleyMember2020-12-3100016489032021-04-290001648903fifg:NotesPayableTwoMember2021-01-012021-12-310001648903fifg:NotesPayableTwoMember2021-04-012021-04-2900016489032021-04-012021-04-290001648903fifg:MarchFirstTwoThousandSeventeenMemberfifg:EmploymentAgreementMemberfifg:MrKeeleyMember2021-12-310001648903fifg:NotesPayableSevenMember2020-12-310001648903fifg:NotesPayableSevenMember2021-12-310001648903fifg:NotesPayablesixMember2020-12-310001648903fifg:NotesPayablesixMember2021-12-310001648903fifg:NotesPayableFiveMember2020-12-310001648903fifg:NotesPayableFiveMember2021-12-310001648903fifg:NotesPayableFourMember2020-12-310001648903fifg:NotesPayableFourMember2021-12-310001648903fifg:NotesPayableThreeMember2020-12-310001648903fifg:NotesPayableThreeMember2021-12-310001648903fifg:NotesPayableTwoMember2020-12-310001648903fifg:NotesPayableTwoMember2021-12-310001648903fifg:NotesPayableOneMember2020-12-310001648903fifg:NotesPayableOneMember2021-12-310001648903fifg:NotesPayableMember2020-12-310001648903fifg:NotesPayableMember2021-12-310001648903fifg:WarrantsMember2021-12-310001648903fifg:WarrantsMember2020-12-310001648903fifg:HolyCacaoMember2021-12-310001648903fifg:HolyCacaoMember2017-12-310001648903fifg:TIERMerchantAdvancesLLCMember2021-01-012021-12-310001648903us-gaap:SeriesCPreferredStockMember2021-01-012021-12-310001648903us-gaap:SeriesCPreferredStockMember2020-01-012020-12-310001648903us-gaap:PropertyPlantAndEquipmentMember2020-01-012020-12-310001648903us-gaap:PropertyPlantAndEquipmentMember2021-01-012021-12-310001648903fifg:HolyCacaoMember2021-01-012021-12-310001648903fifg:HolyCacaoMember2020-01-012020-12-310001648903fifg:EquipmentsMember2021-01-012021-12-310001648903fifg:SeriesAConvertiblePreferredStockMember2021-01-012021-12-310001648903fifg:MerchantCashAdvancesMember2021-01-012021-12-310001648903fifg:WholesaleProductsMember2021-01-012021-12-310001648903fifg:ChocolateProductsMember2021-01-012021-12-310001648903fifg:ChocolateProductsMember2021-12-310001648903fifg:MerchantCashAdvancesMember2020-01-012020-12-310001648903fifg:WholesaleProductsMember2021-12-310001648903fifg:WholesaleProductsMember2020-01-012020-12-310001648903fifg:MerchantCashAdvancesMember2021-12-310001648903fifg:ChocolateProductsMember2020-01-012020-12-310001648903us-gaap:NoncontrollingInterestMember2021-12-310001648903fifg:TotalFirstFoodsGroupIncDeficitMember2021-12-310001648903us-gaap:RetainedEarningsMember2021-12-310001648903us-gaap:AdditionalPaidInCapitalMember2021-12-310001648903us-gaap:CommonStockMember2021-12-310001648903us-gaap:PreferredStockMember2021-12-310001648903us-gaap:NoncontrollingInterestMember2021-01-012021-12-310001648903fifg:TotalFirstFoodsGroupIncDeficitMember2021-01-012021-12-310001648903us-gaap:RetainedEarningsMember2021-01-012021-12-310001648903us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001648903us-gaap:CommonStockMember2021-01-012021-12-310001648903us-gaap:PreferredStockMember2021-01-012021-12-310001648903us-gaap:NoncontrollingInterestMember2020-12-310001648903fifg:TotalFirstFoodsGroupIncDeficitMember2020-12-310001648903us-gaap:RetainedEarningsMember2020-12-310001648903us-gaap:AdditionalPaidInCapitalMember2020-12-310001648903us-gaap:CommonStockMember2020-12-310001648903us-gaap:PreferredStockMember2020-12-310001648903us-gaap:NoncontrollingInterestMember2020-01-012020-12-310001648903fifg:TotalFirstFoodsGroupIncDeficitMember2020-01-012020-12-310001648903us-gaap:RetainedEarningsMember2020-01-012020-12-310001648903us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-310001648903us-gaap:CommonStockMember2020-01-012020-12-310001648903us-gaap:PreferredStockMember2020-01-012020-12-3100016489032019-12-310001648903us-gaap:NoncontrollingInterestMember2019-12-310001648903fifg:TotalFirstFoodsGroupIncDeficitMember2019-12-310001648903us-gaap:RetainedEarningsMember2019-12-310001648903us-gaap:AdditionalPaidInCapitalMember2019-12-310001648903us-gaap:CommonStockMember2019-12-310001648903us-gaap:PreferredStockMember2019-12-3100016489032020-01-012020-12-310001648903fifg:SeriesCConvertiblePreferredStockMemberMember2021-12-310001648903fifg:SeriesCConvertiblePreferredStockMemberMember2020-12-310001648903fifg:SeriesCConvertiblePreferredStockMember2020-12-310001648903fifg:SeriesCConvertiblePreferredStockMember2021-12-310001648903us-gaap:SeriesBPreferredStockMember2020-12-310001648903us-gaap:SeriesBPreferredStockMember2021-12-310001648903fifg:SeriesAConvertiblePreferredStockMember2020-12-310001648903fifg:SeriesAConvertiblePreferredStockMember2021-12-3100016489032020-12-3100016489032021-12-3100016489032022-04-1200016489032021-06-30iso4217:USDxbrli:sharesiso4217:USDxbrli:sharesxbrli:pure
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
☒
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
For the fiscal year ended December 31,
2021
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
For the transition period from ___________ to _____________
Commission file number: 333-206260
FIRST FOODS GROUP,
INC.
|
(Exact name of registrant as specified in its charter)
|
Nevada
|
|
47-4145514
|
(State or other jurisdiction of
incorporation or organization)
|
|
IRS Employer
(Identification No.)
|
|
|
|
First Foods Group, Inc.c/o Incorp Services,
Inc.,
3773 Howard Hughes Parkway, Suite 500S
Las Vegas, NV
|
|
89169-6014
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including area code:
(201)
471-0988
Securities registered pursuant to section 12(b) of the Act:
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
|
|
|
|
None
|
Securities registered pursuant to Section 12(g) of the Securities
Exchange Act: None
Indicate by checkmark if the registrant is a well-known seasoned
issuer, as defined in Rule 405 of the Securities Act. Yes
☐ No ☒
Indicate by checkmark if the registrant is not required to file
reports pursuant to Section 13 or 15(d) of the Act.
Yes ☒ No ☐
Indicate by checkmark whether the registrant has (1) filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements
for the past 90 days. Yes ☐ No
☒
Indicate by check mark whether the registrant has submitted
electronically every Interactive Data File required to be submitted
pursuant to Rule 405 of Regulation S-T during the preceding 12
months (or for such shorter period that the registrant was required
to submit such files). Yes ☒ No ☐
Indicate by checkmark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller
reporting company, or an emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule
12b-2 of the Exchange Act.
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
Non-accelerated Filer
|
☒
|
Smaller reporting company
|
☒
|
Emerging growth company
|
☐
|
|
|
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant has filed a report on
and attestation to its management’s assessment of the effectiveness
of its internal control over financial reporting under Section
404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the
registered public accounting firm that prepared or issued its audit
report. ☐
Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Act). Yes ☐ No ☒
The aggregate market value of voting stock held by non-affiliates
of the registrant was approximately $3,117,394 as of June 30, 2021
(computed by reference to the last sale price of a share of the
registrant’s common stock on that date as reported).
There were 27,058,338 shares of the registrant’s common stock
outstanding as of April 12, 2022.
TABLE OF CONTENTS
PART I
Item 1. Business.
First Foods Group, Inc. (the “Company” or “First Foods”) is a
smaller reporting company focused on developing its specialty
chocolate product line through its Holy Cacao subsidiary,
participating in merchant cash advances (“MCAs”) through its
1st Foods Funding Division, and introducing new
health-related brands, concepts and products through its FFGI
Wholesaling Division.
Holy Cacao is a majority owned subsidiary that is dedicated to
producing, packaging, distributing and selling specialty chocolate
products, including specialty chocolate products infused with a
hemp-based ingredient in accordance with the Company’s
understanding of the Agricultural Act of 2014 (the “2014 Farm
Bill”) and/or the Agriculture Improvement Act of 2018 (the “2018
Farm Bill,” and together with the 2014 Farm Bill, collectively, the
“Farm Bill”), which renders the production of hemp in compliance
with the provisions of the Farm Bill federally lawful. The Company
has not been, is not, and has no current plans to be involved in
producing, packaging, distributing or selling any product that is
infused with a marijuana-based ingredient, although it intends to
revisit the matter as regulations change in jurisdictions in which
it operates.
The Company is also dedicated to licensing its intellectual
property (“IP”), including its name, brand, and packaging, to third
parties. The Company may license its IP to third parties that may
produce, package, and distribute hemp-based products pursuant with
the Company’s understanding of the Farm Bill. The Company may
license its IP to third parties that may produce, package, and
distribute marijuana-based products, but only as such licensing is
legal. Holy Cacao holds four trademarks for the brands, “The
Edibles Cult”, “Purely Irresistible”, “Mystere” and “Southeast
Edibles”.
The Company also has a contract with TIER Merchant Advances LLC
(“TIER”) to participate in the purchase of future receivables from
qualified TIER merchants for the purpose of generating revenue for
the Company. The Company also provides cash advances directly to
merchants.
OUR PRINCIPAL PRODUCTS AND SERVICES
We are primarily focused on developing our specialty chocolate
product line and related IP through our Holy Cacao subsidiary. We
have developed twenty-three (23) proprietary recipes for our
specialty chocolate product line that we have tested in a fully
staffed and fully equipped state of the art manufacturing facility.
We actively market our specialty chocolate product line on a
full-time basis through multiple distribution and sales agreements,
as well as through multiple industry specific trade shows, through
our on-line website presence, and through our ongoing collaboration
with a diverse team of leading industry consultants who specialize
in media relations, public relations, and investor relations.
We are secondarily involved in introducing new health-related
brands, concepts and products through our FFGI Wholesaling Division
and participating in merchant cash advances through our First Foods
Funding Division. The Company participates in the merchant cash
advance industry by directly advancing sums to a merchant or a
merchant advance provider, TIER, who in turn advances sums to
merchants or other merchant cash advance providers.
TARGET MARKET AND OUR NICHE WITHIN
Our highest priority target market consists of chocolate
wholesalers who have a desire to distribute our specialty chocolate
products infused with a hemp-based ingredient to select retailers
throughout the United States.
Our secondary target market consists of health-related products and
merchant cash advance participations. We are aware of an increasing
demand for lending services and products for small businesses, and
we believe the merchant cash advance market is in a growth mode
that presents us with significant opportunity. Furthermore, we
believe the small business lending market is underserved and the
ability of small businesses to obtain credit with traditional
banking institutions is difficult. Our niche approach is to
participate with other syndicated participants in a broad range of
merchant cash advances, as well as selectively issue merchant cash
advances directly to merchants we know well.
COMPETITION, OUR COMPETITIVE STRATEGY AND METHODS OF
COMPETITION
Our competition consists of companies that operate in the specialty
hemp-based chocolate and related health products industry. Our
competitive strategy is to target the consumers of health-related
products and specialty, high-end chocolate products infused with a
hemp-based ingredient.
MARKETING, MARKETING OBJECTIVES AND STRATEGIES
The Company markets its products to existing and emerging food
service companies, focusing specifically on brand development.
Our Marketing Objectives are as follows:
|
•
|
Establishing and promoting our presence in our selected targeted
market; and
|
|
|
|
|
•
|
Building a network of food service industry professional
relationships and referrals.
|
To promote and market our products, we have invoked the following
strategies:
|
•
|
Continued to enhance our online presence via our Company website
reflecting our scope of products offered.
|
|
|
|
|
•
|
Continued online retail sales through our Southeast Edibles
website.
|
|
|
|
|
•
|
Continued to expand our public relations (PR) campaign to obtain
publicity and increase visibility for our business.
|
|
|
|
|
•
|
Retained Michael Kaplan as our Chief Marketing Officer.
|
Currently, the Company’s officers and directors promote our
products through various channels, including networking at local
industry events and Internet sources. The Company does not actively
market its merchant cash advance participation because all
marketing activities are performed by TIER. We anticipate that, as
the Company grows over the next twelve months, pools of expertise
will be acquired by recruiting within the food service and
health-based wholesaling industry and by using technical and
operational consultants, which will allow qualified individuals to
join our management team and Board of Directors.
RESEARCH AND DEVELOPMENT
The Company has engaged market and branding consultants to assist
its master chocolatier with the research and development of
specialty hemp-based chocolate products targeted to particular
states within the US.
EMPLOYEES
The Company’s employees consist of, Mark J. Keeley, who is a
director and our Chief Financial Officer, Moises Davidovits, who is
the Company’s “Master Chocolatier”, and three production assistants
who report to Moises. Harold Kestenbaum is a director consultant
serving in the role of interim Chief Executive Officer. Abraham
Rosenblum is a director serving in the role of Secretary. Michael
Kaplan is a director serving in the role of Chief Marketing
Officer. These individuals, along with director Hershel Weiss, are
responsible for overall Company operations, product development,
sales and marketing, fund raising, implementation of our general
strategy and execution of our business plan. Additionally, our
Master Chocolatier, runs the day-to-day manufacturing, packaging
and distribution of the Company’s specialty hemp-based chocolate
product line.
Our future business and operating results depend significantly on
the continued contributions and active participation of the
aforementioned individuals. These individuals would be difficult or
impossible to replace. The loss of these key contributors, or their
failure to perform, could materially and adversely affect our
Company’s operations. While we may obtain key man insurance, such
insurance may not be sufficient to cover the loss incurred in the
event these individuals are lost.
Our officers and directors receive compensation for their services
and are reimbursed for any out-of-pocket expenses they may incur on
our behalf. We anticipate adding a permanent Chief Operations
Officer over the next twelve (12) months and other employees and
consultants as deemed necessary. We do not currently have any
benefits, such as health or life insurance, available to our
employee or directors.
Item 1A. Risk Factors.
Our current and prospective investors should carefully consider the
following risks and all other information contained in this report,
including our audited consolidated financial statements and the
related notes, “Management’s Discussion and Analysis of Financial
Condition and Results of Operations” and the “Cautionary Note
Regarding Forward-Looking Statements,” before making investment
decisions regarding our securities. The risks and uncertainties
described below are not the only ones we face, but include the most
significant factors currently known by us. Additional risks and
uncertainties that we are unaware of, or that we currently believe
are not material, also may become important factors that affect us.
If any of the following risks materialize, our business, financial
condition and results of operations could be materially harmed. In
that case, the trading price of our securities could decline, and
you may lose some or all of your investment.
Risks Related to Our Business:
We have limited
operating history, our financial position is not robust, and we
lack profitable operations to date.
The Company has incurred net losses since inception and will likely
continue to incur net losses while it builds its business and as
such it may not achieve or maintain profitability. The Company’s
limited operating history makes it difficult to evaluate its
business and prospects, and there is no assurance that the business
of the Company will grow or that it will become profitable. For the
year ended December 31, 2021, the Company had a purchase
concentration of 79% from one vendor. The concentration of the
Company’s purchases creates a potential risk to future supply in
the event that the Company is not able to obtain supplies from
other vendors.
We have limited
cash on hand which creates substantial doubt about our ability to
continue as a going concern.
In their reports for the years ended December 31, 2021 and 2020,
our auditors have expressed that substantial doubt exists about our
ability to continue as a going concern. We have incurred operating
losses since our formation and expect to incur losses and negative
operating cash flows for the twelve months following the audit
report. We also expect to continue to incur significant operating
and capital expenditures and anticipate that our expenses will
increase substantially in the foreseeable future. As a result, we
will need to generate significant revenues or otherwise raise funds
in order to achieve and maintain profitability. Our failure to
achieve or maintain profitability could negatively impact the value
of our common stock.
We will need
additional financing which may not be
available.
Since our formation, we have raised substantial equity and debt
financing to support the growth of our business. Because we intend
to continue to make investments to support the growth of our
business, we require additional capital to pursue our business
objectives and growth strategy and respond to business
opportunities, challenges or unforeseen circumstances, including
participating in merchant cash advances. Accordingly, on a regular
basis we need, or we may need, to engage in equity or debt
financings to secure additional funds. However, additional funds
may not be available when we need them, in amounts we need, on
terms that are acceptable to us or at all. Volatility in the credit
markets in general or in the market for small business or merchant
cash advances in particular may also have an adverse effect on our
ability to obtain debt financing. Furthermore, the cost of our
borrowing may increase due to market volatility, changes in the
risk premiums required by lenders or if traditional sources of debt
capital are unavailable. Volatility or depressed valuations or
trading prices in the equity markets may similarly adversely affect
our ability to obtain equity financing. If we raise additional
funds through further issuances of equity or convertible debt
securities, our existing stockholders could suffer significant
dilution and any new equity securities we issue could have rights,
preferences and privileges superior to those of holders of our
common stock. In particular, we may require additional access to
capital to support our merchant cash advance participation. In
order to participate in merchant cash advances, we have used, and
expect to continue to use, our available cash on hand. If we are
unable to adequately maintain our cash resources, we may delay
non-essential capital expenditures; implement cost cutting
procedures; delay or reduce future hiring; or reduce our rate of
future participation compared to the current level. There can be no
assurance that we can obtain sufficient sources of external capital
to support the growth of our business. Delays in doing so or
failure to do so may require us to reduce merchant cash advance
participation or reduce our operations, which would harm our
ability to pursue our business objectives as well as harm our
business, operating results and financial condition.
We may not be
successful in our potential business
combinations.
The Company may, in the future, pursue acquisitions of other
complementary businesses. The Company may also pursue strategic
alliances and joint ventures that leverage its core industry
experience to expand its product offerings and geographic presence.
The Company has limited experience with respect to acquiring other
companies and limited experience with respect to forming
collaborations, strategic alliances and joint ventures. If the
Company were to make any acquisitions, it may not be able to
integrate these acquisitions successfully into its existing
business and could assume unknown or contingent liabilities. Any
future acquisitions the Company makes could also result in large
and immediate write-offs or the incurrence of debt and contingent
liabilities, any of which could harm the Company’s operating
results. Integrating an acquired company also may require
management resources that otherwise would be available for ongoing
development of the Company’s existing business.
If we fail to
attract and retain key personnel, our business and operating
results may be harmed.
Our future success depends to a significant degree on the skills,
experience and efforts of key personnel in our senior management,
whose vision for our company, knowledge of our business and
expertise would be difficult to replace. If any one of our key
personnel leaves, is unable to work, or fails to perform and we are
unable to find a qualified replacement, we may be unable to execute
our business strategy.
The specialty food
industry is very competitive, which may result in limited revenue
for us, as well as increased expenses associated with marketing our
products.
The specialty food business is highly competitive. We have retained
a Chief Marketing Officer to expand our wholesale and retail market
presence. We plan to compete against other providers of quality
foods, some of which sell their services globally, and some of
these providers have considerably greater resources than we have.
These competitors may have greater marketing and sales capacity,
established distribution networks, significant goodwill and global
name recognition.
We may license our
Holy Cacao name, brand, and recipes, and sell the Company’s Holy
Cacao packaging material in those states where such activity is
legal.
New legislation or regulation, or the application of existing laws
and regulations to the medical and consumer hemp industries could
add additional costs and risks to doing business. We and our
licensees, if any, will be subject to regulations applicable to
businesses generally and laws or regulations directly applicable to
communications over the Internet and access to e-commerce. It is
reasonable to assume that as hemp use becomes more mainstream that
the Food and Drug Administration (FDA) and or other federal, state
and local governmental agencies will impose regulations covering
the purity, privacy, quality control, security and many other
aspects of the industry, all of which will likely raise the cost of
compliance thereby reducing profits or even making it more
difficult to continue operations, either of which scenarios, if
they occur, could have a negative impact on our business and
operations.
The market may not
readily accept our products.
Demand and market acceptance for our licensed brand and packaging
for our hemp infused products are subject to a high level of
uncertainty. This will also be true as we try to expand into the
wholesaling of additional health-related products. The successful
introduction of any new product requires a focused, efficient
strategy to create awareness of and desire for the products. Our
marketing strategy may be unsuccessful and is subject to change as
a result of a number of factors, including changes in market
conditions (including the emergence of new market segments which in
our judgment can be readily exploited through the use of our
technology), the nature of possible license and distribution
arrangements and strategic alliances which may become available to
us in the future and general economic, regulatory and competitive
factors. There can be no assurance that our strategy will result in
successful product commercialization or that our efforts will
result in initial or continued market acceptance for our buyer’s
proposed products. We currently have only limited resources to
enhance our technology or to develop new products.
If we are unable to
protect our intellectual property rights, competitors may be able
to use our technology or trademarks, which could weaken our
competitive position.
We rely on a combination of copyright, trademark and trade secret
laws and restrictions on disclosure to protect our intellectual
property rights. We also intend to enter into confidentiality or
license agreements with our employees, consultants and customers,
and control access to and distribution of our packaging and other
proprietary information. Despite our efforts to protect our
proprietary rights, unauthorized parties may attempt to copy or
otherwise obtain and use our products.
We have entered
into the Merchant Cash Advance (“MCA”) business which carries
separate risk from the food industry.
Reliance on proprietary merchant cash advance credit models, which
involve the use of qualitative factors that are inherently
judgmental, could result in merchant defaults which would affect
our profitability.
The MCA
participations and MCA’s that we own will be relatively illiquid,
and we may not be able to liquidate those investments in a timely
manner.
Any MCA participations and MCA’s that we make or otherwise acquire
will likely be relatively illiquid with no established market for
their purchase and sale, and there can be no assurance that we will
be able to liquidate those investments in a timely manner. Although
these investments will likely generate income, the return of
capital and the realization of gains, if any, from such investments
generally will occur only upon the partial or complete disposition
of such MCA participation or advance, or its repayment or
collection.
Our MCA
participations and advances may become uncollectible, and large
amounts of uncollectible participations and advances may materially
affect our performance.
Our MCA participations and advances will be relatively illiquid and
substantial risks are involved. Most, and possibly all, of the
merchants who receive cash advances from the MCA providers we use
are required to sign a confession of judgement, which legally
requires the merchant to pay back the advance, as long as the
merchant continues as a going concern. Although we use background
checks and other forms of due-diligence information to mitigate the
risk of uncollectible debt resulting from bankruptcy, no assurance
can be made that we will be able to do so. If our MCA portfolio
contains a large portion of uncollectible debt, our performance
will likely be negatively affected. In addition, if any business
defaults on an MCA transaction, we may be required to expend monies
in connection with foreclosure proceedings and other remedial
actions, which expenditures could materially and adversely affect
our financial performance. Although our MCA’s, both direct and
syndicated, will be structured so as not to be characterized as
loans, MCA’s present many of the same risks. For example, we may be
unable to collect the full amount of the merchant cash advance
receivable we acquire through an advance. In any such case, here
again we may be required to expend monies in connection with
remedial actions, which expenditures could materially and adversely
affect our financial performance.
We will have the
right to obtain credit lines as part of our investment strategy,
even though we presently do not intend to do so. Any leverage we
incur in building and growing our business may substantially
increase our risk of loss.
Although we do not presently have intentions to obtain credit
lines, we will not be restricted from doing so and we may in the
future determine that this is an effective way to capitalize the
Company. In such a case, the use of leverage (debt) may increase
both net returns as well as risk since we may not be able to pay
interest obligations associated with our own borrowing.
Our MCA
participations may be concentrated, which could lead to increased
risk.
Our MCA participations may be concentrated in a limited number of
investments or investments to one business or affiliated
businesses. Thus, our stockholders may have limited
diversification. In addition, if we make an investment in a single
transaction with the intent of refinancing or selling a portion of
the investment, there is a risk that we will be unable to
successfully complete such a refinancing or sale. This could lead
to increased risk as a result of having an unintended long-term
investment and reduced diversification.
If third parties
default or file for bankruptcy, we could suffer
losses.
We could suffer losses if our MCA recipients were to default. Any
such default or bankruptcy could have a material and adverse impact
on our results of operation, our financial condition and our
business prospects.
We will incur
increased costs and demands upon management as a result of
complying with the laws and regulations affecting public companies,
which could harm our results of operations and our ability to
attract and retain qualified executives and board
members.
As a public company we incur significant legal, accounting, and
other expenses and these expenses will increase after we cease to
be a “smaller reporting company.” In addition, the Sarbanes-Oxley
Act and rules subsequently implemented by the Securities and
Exchange Commission (“SEC”), Nasdaq and the New York Stock Exchange
(“NYSE”), impose various requirements on public companies,
including requiring changes in corporate governance practices. Our
management and other personnel will need to devote a substantial
amount of time to these compliance initiatives. Moreover, we expect
these rules and regulations and future regulations will continue to
increase our legal, accounting and financial compliance costs and
will make some activities more time consuming and costly. For
example, we expect these rules and regulations to make it more
difficult and more expensive for us to obtain director and officer
liability insurance, and we may be required to accept reduced
policy limits and coverage or to incur substantial costs to
maintain the same or similar coverage. These rules and regulations
could also make it more difficult for us to attract and retain
qualified persons to serve on our board of directors or our board
committees or as executive officers. In addition, the
Sarbanes-Oxley Act requires, among other things, that we assess the
effectiveness of our internal control over financial reporting
annually and the effectiveness of our disclosure controls and
procedures quarterly. In particular, we are required to perform
system and process evaluation and testing of our internal control
over financial reporting to allow management to report on, and our
independent registered public accounting firm potentially to attest
to, the effectiveness of our internal control over financial
reporting, as required by Section 404 of the Sarbanes-Oxley Act, or
“Section 404.” As long as we remain a “smaller reporting company”
we may elect to avail ourselves of the exemption from the
requirement that our independent registered public accounting firm
attest to the effectiveness of our internal control over financial
reporting under Section 404. However, we may no longer avail
ourselves of this exemption when we cease to be a “smaller
reporting company” and, when our independent registered public
accounting firm is required to undertake an assessment of our
internal control over financial reporting, the cost of our
compliance with Section 404 will correspondingly increase. Our
compliance with applicable provisions of Section 404 will require
that we incur substantial accounting expense and expend significant
management time on compliance-related issues as we implement
additional corporate governance practices and comply with reporting
requirements. Moreover, if we are not able to comply with the
requirements of Section 404 applicable to us in a timely manner, or
if we or our independent registered public accounting firm
identifies deficiencies in our internal control over financial
reporting that are deemed to be material weaknesses, the market
price of our stock could decline and we could be subject to
sanctions or investigations by the SEC or other regulatory
authorities, which would require additional financial and
management resources. Furthermore, investor perceptions of our
company may suffer if deficiencies are found, and this could cause
a decline in the market price of our stock. Irrespective of
compliance with Section 404, any failure of our internal control
over financial reporting could have a material adverse effect on
our stated operating results and harm our reputation. We expect to
have in place accounting, internal audit and other management
systems and resources that will allow us to maintain compliance
with the requirements of the Sarbanes-Oxley Act at the end of any
phase-in periods permitted by Nasdaq, the NYSE, the SEC and the
JOBS Act. If we are unable to implement these changes effectively
or efficiently, it could harm our operations, financial reporting
or financial results and could result in an adverse opinion on
internal control from our independent registered public accounting
firm.
Our business is
subject to regulation, and changes in laws and regulations
governing our business, or changes in the interpretation of such
laws and regulations, could negatively affect our
business.
Over the last few years, federal and state regulatory and other
policymaking entities have taken an increased interest in
marketplace and online lending, including online small business
lending. For example, in July 2015, the U.S. Department of the
Treasury issued a public request for information regarding
expanding access to credit through online marketplace lending.
Activity in various states has also increased, including in the
states of California and New York. In December 2015, the California
Department of Business Oversight announced an inquiry into the
marketplace lending industry and requested information from
fourteen marketplace and online lenders. The New York Department of
Financial Services opened a formal investigation of marketplace and
online lending in March 2019. In May 2019, the Federal Trade
Commission held a forum, “Strictly Business,” that explored small
business lending practices, regulations, and policies. The forum
consisted of three panels: (1) Overview of the Small Business
Financing Marketplace, (2) Case Study on Merchant Cash Advances,
and (3) Consumer Protection Risks and the Path Ahead. These
initiatives were presented as information gathering projects to
assist federal and state officials in better understanding, among
other things, the methods, role and impact of online and
marketplace lending on credit markets. These initiatives either
have resulted, or are expected to result, in policy recommendations
that could impact merchant cash advance business practices and
operations, if the recommendations result in new laws or
regulations. As of December 31, 2021, the above federal and state
initiatives have not resulted in formal regulation that could
foreclose the future of merchant cash advances as a viable
financial product. However, the aforementioned regulatory
authorities have continued to respond to complaints that provide a
glimpse into what merchant cash advance companies should expect in
a regulated future for the industry. In particular, authorities
consistently warn against the recharacterization of merchant cash
advances as loans, which provides significant guidance for not only
the drafting of MCA agreements, but also the underwriting and
marketing of MCA. Also, if a federal or state regulatory authority
were to enact legislation requiring licensure by commercial lenders
or imposing certain applicable rate caps or other provisions
inconsistent with current merchant cash advance business practices
and alternative solutions were not available, we could be required
to reevaluate our participation in merchant cash advances. We
expect these and other types of legislative and regulatory
activities to continue in the future as marketplace and online
lending grow and become the subject of greater public interest. For
example, with the prospect of easing regulatory burdens at the
federal level under the current administration, some states have
indicated their intention to take more aggressive regulatory
action. We cannot predict the outcome of these or other comparable
future activities, when or whether they will lead to new laws,
regulations or other actions or what they might be. However, the
impact and cost of any possible future changes to laws or
regulations could be substantial and could also require us to
change our business practices and operations in a manner that
adversely impacts our business. Changes in laws or regulations,
including recent changes under the Tax Cuts and Jobs Act of 2017
(and any related Treasury regulations, rules or interpretations, if
and when issued), or the regulatory application or judicial
interpretation of the laws and regulations applicable to us could
adversely affect our ability to operate in the manner in which we
currently conduct business or make it more difficult or costly for
us to participate in merchant cash advances. A material failure to
comply with any such laws or regulations could result in regulatory
actions, lawsuits and damage to the merchant cash advance industry,
which could have a material adverse effect on our business and
financial condition. A proceeding relating to one or more
allegations or findings of our merchant cash advance provider’s
violation of such laws could impair the ability to collect payments
on advances or to participate in additional advances.
Public perception
of merchant cash advance businesses as predatory or abusive could
adversely affect our business.
In recent years, much of the media reporting on the merchant cash
advance industry has focused on the cost to a small business for
this type of financing arrangement, which is higher than the
interest typically charged by traditional banking institutions in
situations where they are willing to engage in traditional credit
transactions. On occasion, media reports have characterized
merchant cash advance businesses as predatory or abusive toward
small business clients. If this negative characterization of our
business becomes widely accepted, demand for our services could
significantly decrease, which could adversely affect our results of
operations primarily by decreasing our revenues. Negative
perception of our business activities could also result in our
industry being subject to more restrictive laws and regulations and
greater exposure to litigation.
General economic
conditions will likely affect our charge-offs and demand for our
services, and accordingly, our results of operations could be
adversely affected by a general economic slowdown or other negative
economic conditions.
Provision for MCA participation losses and MCA losses, net of
recoveries, may comprise one of our largest operating expenses. Any
changes in economic factors that adversely affect MCA customers,
such as an economic downturn or high unemployment, could result in
higher loss experiences than anticipated, which could in turn
adversely affect our charge-offs. Moreover, a sustained
deterioration in the economy would likely cause a decrease in
demand for merchant cash advance services. Any general economic
conditions negatively affecting our charge-offs or demand for our
services could materially and adversely affect our operating
results.
When we make MCA’s
either by ourselves or as part of a syndicated group, we will be
subject to the risk of fraud by small business clients seeking the
advance.
We will be subject to fraud risk whenever we make an MCA by
ourselves or as part of a syndicated group. Small business
recipients of the advance may, for example, present information
that is false. In any such case, we will likely be unable to
collect our receivable relating to an MCA. Widespread fraud of this
type could adversely affect our operating results and the prospects
for our business. This could also be a concern with respect to our
MCA participations.
Coronavirus
(“COVID-19”) creates significant uncertainty regarding potential
business disruptions that could have a material adverse impact on
the Company’s financial position.
In December 2019, a novel strain of coronavirus surfaced
(COVID-19). The spread of COVID-19 around the world through 2021
caused significant volatility in U.S. and international markets.
There is significant uncertainty around the breadth and duration of
business disruptions related to COVID-19, as well as its impact on
the U.S. and international economies. The Company’s financial
position, operations and cash flows as of December 31, 2021 have
been adversely affected, and may be further affected in the future,
by the ongoing outbreak of COVID-19 which in 2020 was declared a
pandemic by the World Health Organization. The ultimate disruption
which may be caused by the outbreak is uncertain; however, it may
result in a material adverse impact on the Company’s financial
position, operations and cash flows. Possible areas that may be
materially affected include, but are not limited to, disruption to
the Company’s labor workforce, unavailability of products and
supplies used in operations, and the decline in value of assets
held by the Company. As of December 31, 2021 and through the filing
date of the audited consolidated financial statements, the Company
has continued to collect receivables from its cash advances but has
experienced payment delinquencies. The Company has taken a reserve
allowance on its MCA’s. As of December 31, 2021, the Company’s Holy
Cacao operations have experienced no disruption in customers and
revenue, labor workforce, availability of products and supplies
used in operations, and the value of assets held by the Company,
including inventories.
Risks Related to
the Securities Markets and Ownership of Our Common and Preferred
Stock
Our Common Stock is
Subject to the “Penny Stock” Rules of the SEC and the Trading
Market in our Securities is Limited, Which Makes Transactions in
Our Stock Cumbersome and May Reduce the Value of an Investment in
Our Stock.
The SEC has adopted Rule 15g-9 which establishes the definition of
a “penny stock,” for the purposes relevant to us, as any equity
security that has a market price of less than $5.00 per share or
with an exercise price, for warrants or options or conversion price
for convertible notes, of less than $5.00 per share, subject to
certain exceptions. For any transaction involving a penny stock,
unless exempt, the rules require:
·
|
that a broker or dealer approve a person’s account for transactions
in penny stocks; and
|
|
|
·
|
the broker or dealer receives from the investor a written agreement
to the transaction, setting forth the identity and quantity of the
penny stock to be purchased.
|
In order to approve a person’s account for transactions in penny
stocks, the broker or dealer must:
·
|
Obtain financial information and investment experience objectives
of the person; and
|
|
|
·
|
Make a reasonable determination that the transactions in penny
stocks are suitable for that person and the person has sufficient
knowledge and experience in financial matters to be capable of
evaluating the risks of transactions in penny stocks.
|
The broker or dealer must also deliver, prior to any transaction in
a penny stock, a disclosure schedule prescribed by the SEC relating
to the penny stock market, which, in highlight form:
·
|
Sets forth the basis on which the broker or dealer made the
suitability determination, and
|
|
|
·
|
That the broker or dealer received a signed, written agreement from
the investor prior to the transaction.
|
Disclosure also has to be made about the risks of investing in
penny stocks in both public offerings and in secondary trading and
about the commissions payable to both the broker-dealer and the
registered representative, current quotations for the securities
and the rights and remedies available to an investor in cases of
fraud in penny stock transactions. Finally, monthly statements have
to be sent disclosing recent price information for the penny stock
held in the account and information on the limited market in penny
stocks.
Generally, brokers may be less willing to execute transactions in
securities subject to the “penny stock” rules. This may make it
more difficult for investors to dispose of our common stock and
cause a decline in the market value of our stock.
Shares eligible for
future sale under Rule 144 and/or Rule 905 may adversely affect the
market for our securities.
From time to time, certain of our stockholders who hold restricted
securities may be eligible to sell all or some of their shares of
common stock by means of ordinary brokerage transactions in the
open market pursuant to and reliant upon certain exceptions
promulgated under the Securities Act. Although current stockholders
may have no current intention or ability to sell their shares, any
substantial sales by holders of our common stock in the future
pursuant to such exceptions may have a material adverse effect on
the market price of our securities.
The price of our
common stock is subjected to volatility.
The market for the Company’s common stock may be highly volatile.
The trading price of the Company’s common stock is subject to wide
fluctuations in response to, among other things, quarterly
variations in operating and financial results, and general economic
and market conditions. In addition, statements or changes in
opinions, ratings, or earnings estimates made by brokerage firms or
industry analysts relating to their markets or relating to the
Company could result in an immediate and adverse effect on the
market price of our common stock. The highly volatile nature of the
Company’s stock prices may cause investment losses for their
shareholders. If securities class action litigation is brought
against the Company, such litigation could result in substantial
costs while diverting management’s attention and resources.
Our Board of
Directors has sole discretion to create new classes of preferred
stock.
Our Certificate of Incorporation authorizes the issuance of
preferred stock with such rights and preferences as our Board of
Directors may determine from time to time in its sole discretion.
Accordingly, under the Certificate of Incorporation, the Board may
designate and issue preferred stock with dividend, liquidation,
conversion, voting, redemption or other rights that could impact
the rights of the holders of our common shares.
Disruptions in
global financial markets and deteriorating global economic
conditions could cause lower returns to
investors.
Disruptions in global financial markets and deteriorating global
economic conditions could adversely affect the value of the
Company’s common stock. The current state of the economy and the
implications of future potential weakening may negatively impact
market fundamentals, resulting in lower revenues and values for the
Company’s business opportunities and investments.
If we fail to
remain current on our reporting requirements, we could be removed
from quotation by the OTCQB, which would limit the ability of
broker-dealers to sell our securities and the ability of
shareholders to sell their securities in the secondary
market.
Companies quoted on the OTCQB must be current in their publicly
filed reports containing information mandated under Section 13 of
the Exchange Act, in order to maintain price quotation privileges
on the OTCQB. If we fail to remain current on our reporting
requirements, we could be removed from the OTCQB. As a result, the
market liquidity for our securities could be adversely affected by
limiting the ability of broker-dealers to sell our securities and
the ability of shareholders to sell their securities in the
secondary market.
We have not
voluntarily implemented various corporate governance
measures.
Federal legislation, including the Sarbanes-Oxley Act of 2002, has
resulted in the adoption of various corporate governance measures
designed to promote the integrity of the corporate management and
the securities markets. Some of these measures have been adopted in
response to legal requirements. Others have been adopted by
companies in response to the requirements of national securities
exchanges, such as the NYSE or Nasdaq, on which their securities
are listed. As directed by Section 404 of the Sarbanes-Oxley Act of
2002 (“SOX 404”), the SEC has adopted rules requiring public
companies to include a report of management on the Company’s
internal control over financial reporting in its annual reports.
While we expect to expend significant resources in developing the
necessary documentation and testing procedures required by SOX 404,
the Company as of this filing does not have effective controls. As
we identify significant deficiencies or material weaknesses in our
internal control over financial reporting that we cannot remediate
in a timely manner, investors and others may lose confidence in the
reliability of our financial statements and our ability to obtain
equity or debt financing could suffer. Also, among the corporate
governance measures that are required under the rules of national
securities exchanges are those that address board of directors’
independence, audit committee oversight and the adoption of a Code
of Ethics. The Company has not adopted exchange-mandated corporate
governance measures and, since our securities are not listed on a
national securities exchange, we are not required to do so. It is
possible that if we were to adopt some or all of these corporate
governance measures, stockholders would benefit from somewhat
greater assurances that internal corporate decisions were being
made by disinterested directors and that policies had been
implemented to define responsible conduct. For example, in the
absence of audit, nominating and compensation committees comprised
of at least a majority of independent directors, decisions
concerning matters such as compensation packages to our senior
officers and recommendations for director nominees may be made by a
majority of directors who have an interest in the outcome of the
matters being decided. Prospective investors should bear in mind
our current lack of corporate governance measures in formulating
their investment decisions.
We have a large
number of authorized but unissued shares of our common and
preferred stock.
We have a large number of authorized but unissued shares of common
and preferred stock, which our management may issue without further
stockholder approval, thereby causing dilution of your holdings of
our common stock. Our management will continue to have broad
discretion to issue shares of our common and preferred stock in a
range of transactions, including capital-raising transactions,
mergers, acquisitions and other transactions, without obtaining
stockholder approval. If our management determines to issue shares
of our common or preferred stock with conversion rights or special
voting rights from the large pool of authorized but unissued shares
for any purpose in the future, your ownership position would be
diluted without your further ability to vote on that transaction.
Under the Company’s Certificate of Incorporation, the Board of
Directors may designate and issue preferred stock with dividend,
liquidation, conversion, voting, redemption or other rights that
are senior in right to common stock. For example, the Company’s
Class A Preferred Stock provides 50% voting rights to the Company’s
two founding Directors.
Shares of our
common stock may continue to be subject to illiquidity because our
shares may continue to be thinly traded and may never become
eligible for trading on a national securities
exchange.
While we may at some point be able to meet the requirements
necessary for our common stock to be listed on a national
securities exchange, we cannot assure you that we will ever achieve
a listing of our common stock on a national securities exchange.
Our shares are currently only eligible for quotation on the OTCQB,
which is not an exchange. Initial listing on a national securities
exchange is subject to a variety of requirements, including minimum
trading price and minimum public “float” requirements, and could
also be affected by the general skepticism of such markets
concerning companies that are the result of mergers with inactive
publicly-held companies. There are also continuing eligibility
requirements for companies listed on public trading markets. If we
are unable to satisfy the initial or continuing eligibility
requirements of any such market, then our stock may not be listed
or could be delisted. This could result in a lower trading price
for our common stock and may limit your ability to sell your
shares, any of which could result in you losing some or all of your
investments.
The market
valuation of our business may fluctuate due to factors beyond our
control and the value of your investment may fluctuate
correspondingly.
The market valuation of smaller reporting companies, such as us,
frequently fluctuate due to factors unrelated to the past or
present operating performance of such companies. Our market
valuation may fluctuate significantly in response to a number of
factors, many of which are beyond our control, including:
|
i.
|
changes in securities analysts’ estimates of our financial
performance, although there are currently no analysts covering our
stock;
|
|
|
|
|
ii.
|
fluctuations in stock market prices and volumes, particularly among
securities of emerging growth companies;
|
|
|
|
|
iii.
|
changes in market valuations of similar companies;
|
|
|
|
|
iv.
|
announcements by us or our competitors of significant contracts,
acquisitions, commercial relationships, joint ventures or capital
commitments;
|
|
|
|
|
v.
|
variations in our quarterly operating results;
|
|
|
|
|
vi.
|
fluctuations in related commodities prices;
|
|
|
|
|
vii.
|
additions or departures of key personnel; and
|
|
|
|
|
viii.
|
new industry regulations associated with hemp.
|
As a result, the value of your investment in us may fluctuate.
We have never paid
dividends on our common stock.
We have never paid cash dividends on our common stock and do not
presently intend to pay any dividends in the foreseeable future.
Investors should not look to dividends as a source of income. In
the interest of reinvesting initial profits back into our business,
we do not intend to pay cash dividends in the foreseeable future.
Consequently, any economic return will initially be derived, if at
all, from appreciation in the fair market value of our stock, and
not as a result of dividend payments.
Insiders have
substantial control over us, which could limit your ability to
influence the outcome of key transactions, including a change of
control.
Two of our directors have perpetual voting rights with respect to
all company matters. They may have interests that differ from yours
and may vote in a way with which you disagree and which may be
adverse to your interests. This concentration of voting power may
have the effect of delaying, preventing or deterring a change of
control of our company, could deprive our stockholders of an
opportunity to receive a premium for their common stock as part of
a sale of our company and might ultimately affect the market price
of our common stock.
Item 1B. Unresolved Staff
Comments.
The Company has no SEC staff comments.
Item 2. Properties.
The Company does not own property. The Company pays a fee to Incorp
Services, Inc. to maintain a corporate office headquartered at 3773
Howard Hughes Parkway, Suite 500S, Las Vegas, NV 89169-6014. All
directors and officers of the Company work remotely at no cost to
the Company. The Company has access to and uses a fully staffed and
fully equipped state of the art manufacturing facility in Florida
to produce its specialty chocolate product line.
Item 3. Legal Proceedings.
We were not a party to any legal proceedings that could have a
material adverse effect on the Company’s business, financial
condition or operating results. Further, to the Company’s
knowledge, no such proceedings have been threatened against the
Company.
Item 4. Mine Safety
Disclosures.
Not applicable
PART II
Item 5. Market for Registrant’s Common Equity,
Related Stockholder Matters and Issue Purchases of Equity
Securities.
Market
Information
Our common stock is quoted on the OTC Markets (“OTCQB”) under the
symbol “FIFG.”
The closing sales price of the Company’s common stock on April 12,
2022 was $0.20 per share.
Holders
As of the date of this report there were approximately 50 support
holders of record of Company common stock. This does not include an
indeterminate number of additional persons who hold our common
stock in brokerage accounts and otherwise in “street name.”
Dividends
Holders of common stock are entitled to receive such dividends as
may be declared by the Company’s Board of Directors. The Company
did not declare or pay dividends on our common stock during the
years ended December 31, 2021 and 2020.
Transfer Agent and
Registrar
The transfer agent and registrar for First Foods’ common stock is
Manhattan Transfer Registrar Co., 38B Sheep Pasture Rd. Port
Jefferson, NY 11777, telephone 631-928-7655.
Authorization of
Our Securities
On October 25, 2017, and as amended on November 2, 2018, the Board
of Directors of the Company designated 100,000,000 authorized
common shares and 20,000,000 authorized preferred shares to have
preferences and terms as shall be determined by the Board of
Directors from time to time. The preferred shares were authorized
into three series: Series A Convertible Preferred Shares was
designated with one share, which share is issued and outstanding;
Series B Convertible Preferred Shares was designated with 4,999,999
shares, of which 354,999 shares are issued and outstanding; and
Series C Convertible Preferred Shares was designated with 3,000,000
shares, of which 660,000 shares are issued and outstanding.
The Series A Convertible Preferred Share has voting rights equal to
fifty percent (50%) of the voting rights of all outstanding classes
of capital stock of the Company and the share is convertible into
five (5) shares of the Company’s common stock, including
liquidation preference over common stock.
Series B Convertible Preferred Shares have voting rights equal to
five (5) votes per share and each share is convertible into five
(5) shares of the Company’s common stock, including liquidation
preference over common stock.
Series C Convertible Preferred Shares have voting rights equal to
one (1) vote per share and each share is convertible into one (1)
share of the Company’s common stock, including liquidation
preference over common stock.
Repurchases of Our
Securities
None of the shares of our common stock were repurchased by the
Company during the years ended December 31, 2021 and 2020.
Unregistered Sales
of Securities
The Company issued warrants to purchase up to 1,148,775 and
3,496,000 shares of the Company’s common stock during the years
ended December 31, 2021 and 2020, respectively.
The Company did not issue warrants to purchase the Company’s
preferred series B during the year ended December 31, 2021.
However, the Company issued warrants to purchase up to 500,000
shares of the Company’s preferred series B stock during the year
ended December 31, 2020.
The unregistered sales of the warrants were issued pursuant to
Section 4(a)(2) of the Securities Act of 1933, as amended (the
“Act”). No underwriters were retained to serve as placement agents
for the sales and the warrants. The Preferred Shares were sold
directly through our management. No commission or other
consideration was paid in connection with the sales of the warrants
and there was no advertisement or general solicitation made in
connection with the offer and sales of the warrants.
Item 6. [Reserved]
Item 7. Management’s Discussion and Analysis of
Financial Condition and Results of Operations.
Cautionary
Statements.
This annual report contains “forward-looking statements,” as that
term is used in federal securities laws, about First Foods Group,
Inc.’s financial condition, results of operations and business.
These statements include, among others:
•
|
statements concerning the potential benefits that First Foods
Group, Inc. (“First Foods”, “we”, “our”, “us”, the “Company”, or
“management”) may experience from its business activities and
certain transactions it contemplates or has completed; and
|
|
|
•
|
statements of First Foods’ expectations, beliefs, future plans and
strategies, anticipated developments and other matters that are not
historical facts. These statements may be made expressly in this
Form 10-K. You can find many of these statements by looking for
words such as “believes,” “expects,” “anticipates,” “estimates,”
“opines,” or similar expressions used in this Form 10-K. These
forward-looking statements are subject to numerous assumptions,
risks and uncertainties that may cause First Foods’ actual results
to be materially different from any future results expressed or
implied by First Foods in those statements. The most important
facts that could prevent First Foods from achieving its stated
goals include, but are not limited to, the following:
|
|
(a)
|
volatility or decline of First Foods’ stock price;
|
|
|
|
|
(b)
|
potential fluctuation of quarterly results;
|
|
|
|
|
(c)
|
failure of First Foods to earn significant revenues or profits;
|
|
|
|
|
(d)
|
inadequate capital to continue or expand its business, and
inability to raise additional capital or financing to implement its
business plans;
|
|
|
|
|
(e)
|
decline in demand for First Foods’ products and services;
|
|
|
|
|
(f)
|
rapid adverse changes in markets;
|
|
|
|
|
(g)
|
litigation with or legal claims and allegations by outside parties
against First Foods, including but not limited to challenges to
First Foods’ intellectual property rights;
|
|
|
|
|
(h)
|
reliance on proprietary merchant advance credit models, which
involve the use of qualitative factors that are inherently
judgmental and which could result in merchant defaults; and
|
|
|
|
|
(i)
|
New regulations impacting the business.
|
In addition, there is no assurance that (i) First Foods will be
profitable, (ii) First Foods will be able to successfully develop,
manage or market its products and services, (iii) First Foods will
be able to attract or retain qualified executives and personnel,
(iv) First Foods will be able to obtain customers for its products
or services, (v) additional dilution in outstanding stock ownership
will not be incurred due to the issuance of more shares, warrants
and stock options, or the exercise of outstanding warrants and
stock options, and (vi) there are no other risks inherent in First
Foods’ business.
Because the forward-looking statements are subject to risks and
uncertainties, actual results may differ materially from those
expressed or implied by the forward-looking statements. First Foods
cautions you not to place undue reliance on the statements, which
speak only of management’s plans and expectations as of the date of
this Form 10-K. The cautionary statements contained or referred to
in this section should be considered in connection with any
subsequent written or oral forward-looking statements that First
Foods or persons acting on its behalf may issue. First Foods does
not undertake any obligation to review or confirm analysts’
expectations or estimates or to release publicly any revisions to
any forward-looking statements to reflect events or circumstances
after the date of this Form 10-K, or to reflect the occurrence of
unanticipated events.
General
The Company is currently a “smaller reporting company” under the
JOBS Act. A company loses its “smaller reporting company” status on
(i) the day its public float becomes greater than or equal to
$250,000,000 or (ii) had annual revenues of less than $100,000,000
and either: (A) had no public float or (B) had a public float of
less than $700,000,000. As a “smaller reporting company,” First
Foods is exempt from certain obligations of the Exchange Act,
including those found in Section 14A(a) and (b) related to
shareholder approval of executive compensation and golden parachute
compensation and Section 404(b) of the Sarbanes-Oxley Act of 2002
related to the requirement that management assess the effectiveness
of the Company’s internal control for financial reporting.
Furthermore, Section 103 of the JOBS Act provides that as a
“smaller reporting company”, First Foods is not required to comply
with the requirement to provide an auditor’s attestation of ICFR
under Section 404(b) of the Sarbanes-Oxley Act for as long as First
Foods qualifies as a “smaller reporting company.” In addition, a
“smaller reporting company” may include less extensive narrative
disclosure than required of other reporting companies, particularly
in the description of executive compensation and provide audited
financial statements for two fiscal years, in contrast to other
reporting companies, which must provide audited financial
statements for three fiscal years. However, a “smaller reporting
company” is not exempt from the requirement to perform management’s
assessment of internal control over financial reporting.
First Foods is focused on developing its specialty chocolate
product line through its Holy Cacao subsidiary, participating in
merchant cash advances (“MCAs”) through its 1st Foods
Funding Division, and introducing new health-related brands,
concepts and products through its FFGI Wholesaling Division.
Holy Cacao is a majority owned subsidiary that is dedicated to
producing, packaging, distributing and selling specialty chocolate
products, including specialty chocolate products infused with a
hemp-based ingredient in accordance with the Company’s
understanding of the Agricultural Act of 2014 (the “2014 Farm
Bill”) and/or the Agriculture Improvement Act of 2018 (the “2018
Farm Bill,” and together with the 2014 Farm Bill, collectively, the
“Farm Bill”), which renders the production of hemp in compliance
with the provisions of the Farm Bill federally lawful. The Company
has not been, is not, and has no current plans to be involved in
producing, packaging, distributing or selling any product that is
infused with a marijuana-based ingredient, although it intends to
revisit the matter as regulations change in jurisdictions in which
it operates.
The Company is also dedicated to licensing its intellectual
property (“IP”), including its name, brand, and packaging, to third
parties. The Company may license its IP to third parties that may
produce, package, and distribute hemp-based products pursuant with
the Company’s understanding of the Farm Bill. The Company may
license its IP to third parties that may produce, package, and
distribute marijuana-based products, but only as such licensing is
legal. Holy Cacao holds four trademarks for the brands, “The
Edibles Cult”, “Purely Irresistible”, “Mystere” and “Southeast
Edibles”.
The Company also has a contract with TIER Merchant Advances LLC
(“TIER”) to participate in the purchase of future receivables from
qualified TIER merchants for the purpose of generating near-term
and long-term revenue for the Company. The Company also provides
cash advances directly to merchants.
The Company is quoted on the OTCQB under “FIFG.”
The Company’s principal executive offices are located at First
Foods Group, Inc. c/o Incorp Services, Inc., 3773 Howard Hughes
Parkway, Suite 500S, Las Vegas, NV 89169-6014. Our telephone number
is (201) 471-0988.
As of December 31, 2021, our cash balance was $11,527, which
includes restricted cash of $5,900, and our current liabilities
were $3,732,377.
Results of Operations
Results of Operations for the Year Ended December 31, 2021
compared to the Year Ended December 31, 2020
Fiscal 2021 Highlights
Total net sales increased 74% or $154,590 during 2021 compared to
2020, driven by growth in our wholesale and Chocolate Products.
Products Performance
|
|
|
|
|
|
|
|
|
|
The following table shows net sales by category for 2021 and
2020:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
|
Change
|
|
|
2020
|
|
Net sales by category:
|
|
|
|
|
|
|
|
|
|
Chocolate products
|
|
$ |
94,387 |
|
|
|
93 |
% |
|
$ |
48,983 |
|
Wholesale products
|
|
|
228,697 |
|
|
|
100 |
% |
|
|
- |
|
Merchant cash advances
|
|
|
39,673 |
|
|
|
-75 |
% |
|
|
159,184 |
|
Total net sales
|
|
$ |
362,757 |
|
|
|
74 |
% |
|
$ |
208,167 |
|
Chocolate products
Chocolate products net sales increased during 2021 compared to 2020
due primarily to the product being in the market for the full year
in 2021 as compared to only a few months in 2020.
Wholesale products
Wholesale products net sales increased during 2021 compared to 2020
due to the wholesale division starting in 2021. The Company does
not plan on continuing the Wholesale division and will be focusing
its resources on the Chocolate division.
Merchant cash advances
Merchant cash advances net sales decreased during 2021 compared to
2020 due to the Company winding down that division to focus and put
resources to the Chocolate producing division of the Company.
Cost of Product Sales
Products cost of sales for 2021 and 2020 were as follows:
|
|
2021
|
|
|
2020
|
|
Cost of Product Sales:
|
|
|
|
|
|
|
Chocolate products
|
|
$ |
32,564 |
|
|
$ |
35,077 |
|
Wholesale products
|
|
|
200,683 |
|
|
|
- |
|
Total Cost of Product Sales:
|
|
$ |
233,247 |
|
|
$ |
35,077 |
|
Cost of product sales
The increase in cost of product sales in 2021 as compared to 2020
was due to an increase in FFGI wholesale product sales which has a
narrow gross margin when compared to the Holy Cacao sales. Cost of
Chocolate sales decreased due to scale and better efficiencies.
Legal fees for the year ended December 31, 2021 was $35,019
compared to $61,641 for the year ended December 31, 2020. This
decrease in legal fees was due to fewer contractual obligations
being signed which led to lower legal expenses.
General and administrative expenses for the year ended December 31,
2021 was $1,702,035 compared to $1,993,427 for the year ended
December 31, 2020. The decrease in general and administrative
expenses was primarily due to decreased costs associated with
stock-based compensation, and consulting and accounting fees.
Provision for merchant cash advances for the year ended December
31, 2021 was $(154,303) compared to $141,790 for the year ended
December 31, 2020. The decrease in provision for merchant cash
advances was due to a decrease in our reserve allowance for our
merchant cash advances related to COVID-19 as the Company had a
much higher collection rate than expected following the Discuss
impairment.
Impairment of assets expense for the year ended December 31, 2021
was $46,368. The company has not realized cash flows sufficient to
overcome an asset impairment and is, therefore, estimating an
impairment of 25% of its asset carrying value. There was no
impairment expense in the year ended December 31, 2020.
Liquidity and Capital Resources
Net cash used in operating activities amounted to $333,692 for the
year ended December 31, 2021 and $163,541 for the year ended
December 31, 2020. This resulted in a working capital deficit of
$3,536,485 at December 31, 2021 and $2,560,983 at December 31,
2020. This decrease in working capital was due primarily to an
increase in accounts payable and accrued expenses and an increase
in loans.
Net cash used in investing activities amounted to $877 for the year
ended December 31, 2021 and $199,328 for the year ended December
31, 2020. This was due to more purchases of equipment in 2020 as
the company was making additions to equip the factory as compared
to 2021.
Net cash provided by financing activities amounted to $295,710 for
the year ended December 31, 2021 and $388,902 for the year ended
December 31, 2020. This was due to a decrease of proceeds from the
issuance of loans in 2021 as compared to 2020.
Concentration Risks
The Company recognizes the concentration of its merchant cash
advances, which could inherently create a potential risk to future
working capital in the event that the Company is not able to
collect all, or a majority, of the outstanding merchant cash
advances. The Company actively mitigates its portfolio
concentration risk by monitoring its merchant cash advance
provider’s ability to participate in merchant cash advances from
alternative providers and spreading merchant cash advance
participation across various merchants.
As of December 31, 2021, the Company’s receivables from merchant
cash advances included $29,290 from one merchant, representing 78%
of the Company’s merchant cash advances. The Company earned $22,368
of MCA income from one merchant, representing 56% of the Company’s
MCA income for the twelve months ended December 31, 2021.
As of December 31, 2020, the Company’s receivables from merchant
cash advances included $59,719 from two merchants ($25,929 and
$33,790), representing 49.3% of the Company’s merchant cash
advances. The Company earned $84,525 and $27,175 of MCA income from
two merchants, representing 53.5% and 17.2%, respectively of the
Company’s MCA income for the twelve months ended December 31,
2020.
As of December 31, 2021 and 2020, there was no accounts payable
concentration other than amounts owed to related parties which
makes up 70% and 74% of the balance, respectively.
For the year ended December 31, 2021, the Company had sales
concentrations of 17%, 15% and 15% from three customers. There was
no sales concentration for the year ended December 31, 2020.
For the year ended December 31, 2021, the Company had purchase
concentrations of 79% from one vendor.
For the year ended December 31, 2020, the Company had purchase
concentrations of 49% and 14% from two vendors.
Going Concern
The Company’s consolidated financial statements are prepared using
generally accepted accounting principles in the United States of
America applicable to a going concern which contemplates the
realization of assets and liquidation of liabilities in the normal
course of business.
The Company has not yet established an ongoing source of revenues
sufficient to cover its operating costs and allow it to continue as
a going concern. The ability of the Company to continue as a going
concern is dependent on the Company obtaining adequate capital to
fund operating losses until it becomes profitable. If the Company
is unable to obtain adequate capital, it could be forced to cease
operations.
In order to continue as a going concern, the Company will need,
among other things, additional capital resources. Management’s plan
is to obtain such resources for the Company by obtaining capital
from management and significant shareholders sufficient to meet its
operating expenses and seeking equity and/or debt financing.
However, neither any members of management nor any significant
shareholders are currently committed to invest funds with us and;
therefore, we cannot provide any assurances that the Company will
be successful in accomplishing any of its plans.
The Company does not have sufficient cash flow for the next twelve
months from the issuance of these audited consolidated financial
statements. The ability of the Company to continue as a going
concern is dependent upon its ability to successfully accomplish
the plans described in the preceding paragraph and eventually
secure other sources of financing and attain profitable operations.
The accompanying audited consolidated financial statements do not
include any adjustments that might be necessary, if the Company is
unable to continue as a going concern.
Contractual Obligations
Not applicable.
Critical Accounting Policies
Our discussion and analysis of our financial condition and results
of operations are based upon our consolidated financial statements,
which have been prepared in accordance with accounting principles
generally accepted in the United States of America. The preparation
of these consolidated financial statements requires us to make
estimates and judgments that affect the reported amounts of assets,
liabilities, revenues and expenses, and related disclosure of
contingent assets and liabilities. We monitor our estimates on an
on-going basis for changes in facts and circumstances, and material
changes in these estimates could occur in the future. Changes in
estimates are recorded in the period in which they become known. We
base our estimates on historical experience and other assumptions
that we believe to be reasonable under the circumstances. Actual
results may differ from our estimates if past experience or other
assumptions do not turn out to be substantially accurate.
Certain of our accounting policies are particularly important to
the portrayal and understanding of our financial position and
results of operations and require us to apply significant judgment
in their application. As a result, these policies are subject to an
inherent degree of uncertainty. In applying these policies, we use
our judgment in making certain assumptions and estimates. Our
critical accounting policies are outlined in Note 1 in the Notes to
the Consolidated Financial Statements.
Item 7A. Quantitative and Qualitative
Disclosures About Market Risk.
First Foods is a smaller reporting company as defined by Rule 12b-2
of the Exchange Act and is not required to provide the information
under this item.
Item 8. Financial Statements and Supplementary
Data.
FIRST FOODS GROUP, INC. AND
SUBSIDIARY
CONSOLIDATED FINANCIAL STATEMENTS – TABLE OF CONTENTS
REPORT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM
To the Board of Directors and
Stockholders of First Foods Group, Inc. and Subsidiary
Opinion on the Consolidated Financial
Statements
We have audited the accompanying consolidated balance sheets of
First Foods Group, Inc. and Subsidiary (the “Company”) as of
December 31, 2021 and 2020, and the related consolidated statements
of operations, changes in deficit, and cash flows for each of the
years in the two year period ended December 31, 2021, and the
related notes (collectively referred to as the consolidated
financial statements). In our opinion, the consolidated financial
statements present fairly, in all material respects, the financial
position of the Company as of December 31, 2021 and 2020, and the
results of its operations and its cash flows for each of the years
in the two year period ended December 31, 2021, in conformity with
accounting principles generally accepted in the United States of
America.
Substantial Doubt about the Company’s Ability to Continue
as a Going Concern
The accompanying consolidated financial statements have been
prepared assuming that the Company will continue as a going
concern. As discussed in Note 1 to the consolidated financial
statements, the Company has recurring losses from operations which
raises substantial doubt about its ability to continue as a going
concern. Management’s evaluation of the events and conditions and
management’s plans regarding those matters also are described in
Note 1. The consolidated financial statements do not include any
adjustments that might result from the outcome of this uncertainty.
Our opinion is not modified with respect to that matter.
Basis for Opinion
These consolidated financial statements are the responsibility of
the Company’s management. Our responsibility is to express an
opinion on the Company’s consolidated financial statements based on
our audits. We are a public accounting firm registered with the
Public Company Accounting Oversight Board (United States) (PCAOB)
and are required to be independent with respect to the Company in
accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and
the PCAOB.
We conducted our audits in accordance with the standards of the
PCAOB. Those standards require that we plan and perform the audits
to obtain reasonable assurance about whether the consolidated
financial statements are free of material misstatement, whether due
to error or fraud. The Company is not required to have, nor were we
engaged to perform, an audit of its internal control over financial
reporting. As part of our audits, we are required to obtain an
understanding of internal control over financial reporting, but not
for the purpose of expressing an opinion on the effectiveness of
the Company’s internal control over financial reporting.
Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of
material misstatement of the consolidated financial statements,
whether due to error or fraud, and performing procedures that
respond to those risks. Such procedures included examining, on a
test basis, evidence regarding the amounts and disclosures in the
consolidated financial statements. Our audits also included
evaluating the accounting principles used and significant estimates
made by management, as well as evaluating the overall presentation
of the consolidated financial statements. We believe that our
audits provide a reasonable basis for our opinion.
Critical Audit Matters
The critical audit matters communicated below are matters arising
from the current period audit of the consolidated financial
statements that were communicated or required to be communicated to
the board of directors and that: (1) relate to accounts or
disclosures that are material to the consolidated financial
statements and (2) involved our especially challenging, subjective,
or complex judgments. The communication of critical audit matters
does not alter in any way our opinion on the consolidated financial
statements, taken as a whole, and we are not, by communicating the
critical audit matters below, providing separate opinions on the
critical audit matters or on the accounts or disclosures to which
they relate.
Stock Based Compensation – Initial Measurement of Fair
Value
Description of the Matter
As described in Note 1 of the consolidated financial statements,
the Company measures and recognizes compensation expense for all
stock-based payments at fair value over the requisite service
period. The Company uses the Black-Scholes option pricing model to
determine the grant date fair value of options and warrants. In
particular, management’s estimates were sensitive to assumptions
about the volatility of the Company’s stock price, expected
exercise term and fair value determination method.
How We Addressed the Matter in Our Audit
To test stock based compensation expense, we performed audit
procedures that included, among others, obtaining an understanding
of the Company’s controls over stock-based compensation, assessing
the completeness of the awards granted and evaluating the
methodologies used to estimate the fair value of these awards. We
also tested the accuracy of the data used in measuring the awards
by agreeing the underlying inputs, such as grant date, grant price,
performance targets and vesting terms, among others, back to source
documents, such as board meeting minutes or award letters and
testing the clerical accuracy of the calculation of the expense
recorded. We determined whether milestone targets were satisfied in
accordance with the contractual conditions and recalculated grant
date fair value. We also evaluated the adequacy of the Company’s
stock-based compensation disclosures included in Note 1 in relation
to these matters.
Assessment of Impairment on Long Lived
Assets
Description of the Matter
As described in Note 1 of the consolidated financial statements,
the Company’s long lived tangible assets are stated at cost, less
accumulated depreciation and amortization. The Company’s right of
use assets and operating lease liability are stated at the present
value of remaining lease payments over the lease term using the
Company’s secured incremental borrowing rates, less current period
non cash lease expense and amortization. The Company evaluates its
long-lived assets for impairment whenever events or changes in
circumstances indicate the carrying value of an asset or group of
assets may not be recoverable. If these circumstances exist,
recoverability of assets to be held and used is measured by a
comparison of the carrying amount of an asset group to future
undiscounted net cash flows expected to be generated by the asset
group.
How We Addressed the Matter in Our Audit
Our audit procedures related to the assessment of impairment on
long lived assets we obtained an understanding and evaluated the
procedures over management’s impairment review process. We reviewed
management’s significant assumptions and data inputs utilized in
the calculation of future undiscounted and discounted cash flows.
To test the Company’s estimated future cash flows used to test for
the recoverability of the respective assets and, if applicable, the
measurement of an impairment loss, we performed audit procedures
that included, among others, testing the significant assumptions
discussed above and the underlying data used by the Company in its
impairment analyses, evaluating the methodologies applied by
management, and recalculating the total undiscounted and discounted
cash flows, if applicable, for each asset analyzed. We compared the
significant assumptions used by management to historical sales
data, sales trends, and observable market-specific data. We
assessed the historical accuracy of management’s estimates and
performed sensitivity analyses of significant assumptions to
evaluate the changes in the fair value of the assets that would
result from changes in the assumptions.
/s/ Friedman LLP
|
|
We
have served as the Company’s auditor since 2017.
|
|
|
Marlton, New Jersey
April 14, 2022
|
First Foods Group, Inc. and Subsidiary
|
|
Consolidated Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
December 31,
2021
|
|
|
December 31,
2020
|
|
ASSETS
|
|
CURRENT ASSETS
|
|
|
|
|
|
|
Cash
|
|
$ |
5,627 |
|
|
$ |
50,386 |
|
Restricted cash
|
|
|
5,900 |
|
|
|
- |
|
Inventory, net
|
|
|
56,936 |
|
|
|
46,240 |
|
Merchant cash advances, net of allowance $131,703 and $291,380,
respectively
|
|
|
37,541 |
|
|
|
121,079 |
|
Prepaid expenses and other current assets
|
|
|
89,888 |
|
|
|
148,805 |
|
TOTAL CURRENT ASSETS
|
|
|
195,892 |
|
|
|
366,510 |
|
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
|
139,103 |
|
|
|
242,438 |
|
Operating lease right-of-use assets
|
|
|
177,062 |
|
|
|
239,247 |
|
TOTAL ASSETS
|
|
$ |
512,057 |
|
|
$ |
848,195 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND DEFICIT
|
CURRENT LIABILITIES
|
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities
|
|
$ |
1,074,216 |
|
|
$ |
645,092 |
|
Accounts payable and accrued liabilities - related parties
|
|
|
718,114 |
|
|
|
465,506 |
|
Put liability
|
|
|
29,421 |
|
|
|
- |
|
Deferred revenue
|
|
|
81,953 |
|
|
|
105,058 |
|
Loans, net of unamortized debt discount
|
|
|
1,288,586 |
|
|
|
966,155 |
|
Related party loans, net of unamortized debt discount
|
|
|
471,009 |
|
|
|
685,279 |
|
Operating lease liabilities
|
|
|
69,078 |
|
|
|
60,403 |
|
TOTAL CURRENT LIABILITIES
|
|
|
3,732,377 |
|
|
|
2,927,493 |
|
|
|
|
|
|
|
|
|
|
Loans - long term
|
|
|
150,000 |
|
|
|
300,024 |
|
Operating lease liabilities - long term
|
|
|
109,975 |
|
|
|
179,053 |
|
TOTAL LIABILITIES
|
|
|
3,992,352 |
|
|
|
3,406,570 |
|
|
|
|
|
|
|
|
|
|
Commitments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DEFICIT
|
|
|
|
|
|
|
|
|
FIRST FOODS GROUP, INC. DEFICIT:
|
|
|
|
|
|
|
|
|
Preferred stock, 20,000,000 shares authorized:
|
|
|
|
|
|
|
|
|
Series A convertible preferred stock: $0.001 par value, 1 share
authorized, 1 issued and outstanding ($577,005 liquidation
preference)
|
|
|
- |
|
|
|
- |
|
Series B convertible preferred stock: $0.001 par value, 4,999,999
shares authorized, 354,999 and 473,332 issued and outstanding,
respectively ($118,235 and $160,000 liquidation preference,
respectively)
|
|
|
355 |
|
|
|
473 |
|
Series C convertible preferred stock: $0.001 par value, 3,000,000
shares authorized, 660,000 shares issued and outstanding ($165,000
liquidation preference)
|
|
|
660 |
|
|
|
660 |
|
Common stock: $0.001 par value,100,000,000 shares authorized,
26,998,338 and 22,367,179 shares issued and outstanding,
respectively
|
|
|
26,998 |
|
|
|
22,367 |
|
Additional paid-in capital
|
|
|
12,062,341 |
|
|
|
10,515,601 |
|
Accumulated deficit
|
|
|
(15,335,458 |
) |
|
|
(12,954,696 |
) |
Total First Foods Group, Inc. Deficit
|
|
|
(3,245,104 |
) |
|
|
(2,415,595 |
) |
|
|
|
|
|
|
|
|
|
Noncontrolling interests
|
|
|
(235,191 |
) |
|
|
(142,780 |
) |
Total deficit
|
|
|
(3,480,295 |
) |
|
|
(2,558,375 |
) |
TOTAL LIABILITIES AND DEFICIT
|
|
$ |
512,057 |
|
|
$ |
848,195 |
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated
financial statements.
|
First Foods Group, Inc. and Subsidiary
|
Consolidated Statements of
Operations
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
|
|
2021
|
|
|
2020
|
|
|
|
|
|
|
|
|
REVENUES
|
|
|
|
|
|
|
Product sales, net
|
|
$ |
323,084 |
|
|
$ |
48,983 |
|
Merchant cash advance income, net
|
|
|
39,673 |
|
|
|
159,184 |
|
Total Revenues
|
|
|
362,757 |
|
|
|
208,167 |
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES
|
|
|
|
|
|
|
|
|
Cost of product sales
|
|
|
233,247 |
|
|
|
35,077 |
|
Legal fees
|
|
|
35,019 |
|
|
|
61,641 |
|
General and administrative
|
|
|
1,702,035 |
|
|
|
1,993,427 |
|
Provision for merchant cash advances
|
|
|
(154,303 |
) |
|
|
141,790 |
|
Impairment of assets
|
|
|
46,368 |
|
|
|
- |
|
Total Operating Expenses
|
|
|
1,862,366 |
|
|
|
2,231,935 |
|
|
|
|
|
|
|
|
|
|
LOSS FROM OPERATIONS
|
|
|
(1,499,609 |
) |
|
|
(2,023,768 |
) |
|
|
|
|
|
|
|
|
|
OTHER INCOME (EXPENSE)
|
|
|
|
|
|
|
|
|
Other income
|
|
|
110,000 |
|
|
|
1,000 |
|
Loss on extinguishment of loans payable
|
|
|
(412,509 |
) |
|
|
- |
|
Interest expense
|
|
|
(671,055 |
) |
|
|
(720,370 |
) |
|
|
|
|
|
|
|
|
|
Loss before income taxes
|
|
|
(2,473,173 |
) |
|
|
(2,743,138 |
) |
|
|
|
|
|
|
|
|
|
Provision for income taxes
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
NET LOSS
|
|
|
(2,473,173 |
) |
|
|
(2,743,138 |
) |
|
|
|
|
|
|
|
|
|
Non-controlling interest share of loss
|
|
|
92,411 |
|
|
|
81,702 |
|
Deemed dividends
|
|
|
(337,930 |
) |
|
|
- |
|
|
|
|
|
|
|
|
|
|
Net loss attributed to shareholders of First Foods Group, Inc.
|
|
$ |
(2,718,692 |
) |
|
$ |
(2,661,436 |
) |
|
|
|
|
|
|
|
|
|
BASIC AND DILUTED LOSS PER COMMON SHARE ATTRIBUTABLE TO
FIRST FOODS GROUP, INC. STOCKHOLDERS
|
|
$ |
(0.11 |
) |
|
$ |
(0.12 |
) |
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING
ATTRIBUTABLE TO FIRST FOODS GROUP, INC. STOCKHOLDERS - BASIC AND
DILUTED
|
|
|
24,717,458 |
|
|
|
21,449,269 |
|
The accompanying notes are an integral part of these consolidated
financial statements.
First Foods Group, Inc. and Subsidiary
|
Consolidated Statements of Changes in
Deficit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock
|
|
|
Common Stock
|
|
|
Additional
paid-in |
|
|
Accumulated
|
|
|
Total First Foods Group, Inc.
|
|
|
Non-controlling
|
|
|
Total
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
capital
|
|
|
deficit
|
|
|
deficit
|
|
|
interests
|
|
|
deficit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2019
|
|
|
1,133,333 |
|
|
$ |
1,133 |
|
|
|
20,313,771 |
|
|
$ |
20,314 |
|
|
$ |
9,116,998 |
|
|
$ |
(10,293,260 |
) |
|
$ |
(1,154,815 |
) |
|
$ |
(61,078 |
) |
|
$ |
(1,215,893 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued for cash to a related party
|
|
|
- |
|
|
|
- |
|
|
|
499,998 |
|
|
|
500 |
|
|
|
99,500 |
|
|
|
- |
|
|
|
100,000 |
|
|
|
- |
|
|
|
100,000 |
|
Common stock issued to consultants for services
|
|
|
- |
|
|
|
- |
|
|
|
600,000 |
|
|
|
600 |
|
|
|
130,750 |
|
|
|
- |
|
|
|
131,350 |
|
|
|
- |
|
|
|
131,350 |
|
Common stock issued for related party loan
|
|
|
- |
|
|
|
- |
|
|
|
579,410 |
|
|
|
579 |
|
|
|
125,823 |
|
|
|
- |
|
|
|
126,402 |
|
|
|
- |
|
|
|
126,402 |
|
Common stock issued with loans payable
|
|
|
- |
|
|
|
- |
|
|
|
374,000 |
|
|
|
374 |
|
|
|
99,258 |
|
|
|
- |
|
|
|
99,632 |
|
|
|
- |
|
|
|
99,632 |
|
Stock based compensation
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
170,644 |
|
|
|
- |
|
|
|
170,644 |
|
|
|
- |
|
|
|
170,644 |
|
Warrants issued for director services
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
501,911 |
|
|
|
- |
|
|
|
501,911 |
|
|
|
- |
|
|
|
501,911 |
|
Warrants issued with loan payable
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
20,717 |
|
|
|
- |
|
|
|
20,717 |
|
|
|
- |
|
|
|
20,717 |
|
Warrants issued in lieu of deferred compensation
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
250,000 |
|
|
|
- |
|
|
|
250,000 |
|
|
|
- |
|
|
|
250,000 |
|
Net loss
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(2,661,436 |
) |
|
|
(2,661,436 |
) |
|
|
(81,702 |
) |
|
|
(2,743,138 |
) |
Balance at December 31, 2020
|
|
|
1,133,333 |
|
|
$ |
1,133 |
|
|
|
22,367,179 |
|
|
$ |
22,367 |
|
|
$ |
10,515,601 |
|
|
$ |
(12,954,696 |
) |
|
$ |
(2,415,595 |
) |
|
$ |
(142,780 |
) |
|
$ |
(2,558,375 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued for cash to a related party
|
|
|
- |
|
|
|
- |
|
|
|
499,998 |
|
|
|
500 |
|
|
|
99,500 |
|
|
|
- |
|
|
|
100,000 |
|
|
|
- |
|
|
|
100,000 |
|
Stock compensation consultant - Put liability
|
|
|
- |
|
|
|
- |
|
|
|
147,991 |
|
|
|
147 |
|
|
|
(147 |
) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Common stock issued to consultants for services
|
|
|
- |
|
|
|
- |
|
|
|
70,856 |
|
|
|
71 |
|
|
|
9,361 |
|
|
|
- |
|
|
|
9,432 |
|
|
|
- |
|
|
|
9,432 |
|
Common stock issued for related party loan
|
|
|
- |
|
|
|
- |
|
|
|
190,000 |
|
|
|
190 |
|
|
|
38,970 |
|
|
|
- |
|
|
|
39,160 |
|
|
|
- |
|
|
|
39,160 |
|
Common stock issued with loans payable
|
|
|
- |
|
|
|
- |
|
|
|
114,000 |
|
|
|
114 |
|
|
|
19,746 |
|
|
|
- |
|
|
|
19,860 |
|
|
|
- |
|
|
|
19,860 |
|
Common stock issued for conversion of loans payable
|
|
|
- |
|
|
|
- |
|
|
|
1,608,314 |
|
|
|
1,608 |
|
|
|
342,388 |
|
|
|
- |
|
|
|
343,997 |
|
|
|
- |
|
|
|
343,997 |
|
Common stock issued for conversion of loans payable - related
party
|
|
|
- |
|
|
|
- |
|
|
|
2,000,000 |
|
|
|
2,000 |
|
|
|
458,000 |
|
|
|
- |
|
|
|
460,000 |
|
|
|
- |
|
|
|
460,000 |
|
Preferred stock waived by director
|
|
|
(118,333 |
) |
|
|
(118 |
) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(118 |
) |
|
|
- |
|
|
|
(118 |
) |
Stock based compensation
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
236,836 |
|
|
|
- |
|
|
|
236,836 |
|
|
|
- |
|
|
|
236,836 |
|
Warrants issued for director services
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
91,270 |
|
|
|
- |
|
|
|
91,270 |
|
|
|
- |
|
|
|
91,270 |
|
Warrants issued for related party loan
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
67,940 |
|
|
|
- |
|
|
|
67,940 |
|
|
|
- |
|
|
|
67,940 |
|
Warrants issued for conversion of loan payable
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
83,513 |
|
|
|
- |
|
|
|
83,513 |
|
|
|
- |
|
|
|
83,513 |
|
Warrants issued for loan payable
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
47,597 |
|
|
|
- |
|
|
|
47,597 |
|
|
|
- |
|
|
|
47,597 |
|
Modification of warrants
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
51,767 |
|
|
|
- |
|
|
|
51,767 |
|
|
|
- |
|
|
|
51,767 |
|
Net loss
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(2,380,762 |
) |
|
|
(2,380,762 |
) |
|
|
(92,411 |
) |
|
|
(2,473,173 |
) |
Balance at December 31, 2021
|
|
|
1,015,000 |
|
|
$ |
1,015 |
|
|
|
26,998,338 |
|
|
$ |
26,998 |
|
|
$ |
12,062,341 |
|
|
$ |
(15,335,458 |
) |
|
$ |
(3,245,104 |
) |
|
$ |
(235,191 |
) |
|
$ |
(3,480,295 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated
financial statements.
|
First Foods Group, Inc. and Subsidiary
|
Consolidated Statements of Cash
Flows
|
|
|
|
|
For the Years Ended December 31,
|
|
|
|
2021
|
|
|
2020
|
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
|
|
|
Net Loss
|
|
$ |
(2,473,173 |
) |
|
$ |
(2,743,138 |
) |
Adjustments to reconcile net loss to net cash used in operating
activities:
|
|
|
|
|
|
|
|
|
Non-employee stock based compensation
|
|
|
9,432 |
|
|
|
131,350 |
|
Employee stock based compensation
|
|
|
328,106 |
|
|
|
672,555 |
|
Loss on extinguishment of loans payable
|
|
|
412,509 |
|
|
|
- |
|
Impairment of assets
|
|
|
46,368 |
|
|
|
- |
|
Amortization of debt discount
|
|
|
463,751 |
|
|
|
499,986 |
|
Depreciation and amortization expense
|
|
|
57,844 |
|
|
|
37,077 |
|
Change in merchant allowance
|
|
|
(159,677 |
) |
|
|
193,885 |
|
Merchant cash advance direct write off
|
|
|
5,374 |
|
|
|
141,790 |
|
Non-cash lease expense
|
|
|
62,185 |
|
|
|
28,457 |
|
Put liability
|
|
|
29,421 |
|
|
|
- |
|
Forgiveness of preferred series B stock
|
|
|
(118 |
) |
|
|
- |
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Inventory
|
|
|
(10,696 |
) |
|
|
(5,870 |
) |
Merchant cash advances
|
|
|
237,841 |
|
|
|
420,703 |
|
Deferred merchant advance commissions
|
|
|
- |
|
|
|
15,053 |
|
Prepaid expenses and other current assets
|
|
|
58,917 |
|
|
|
(59,922 |
) |
Operating lease liabilities
|
|
|
(60,403 |
) |
|
|
(28,248 |
) |
Accounts payable and accrued liabilities
|
|
|
429,124 |
|
|
|
454,246 |
|
Accounts payable and accrued liabilities - related party
|
|
|
252,608 |
|
|
|
166,640 |
|
Deferred revenue
|
|
|
(23,105 |
) |
|
|
(88,105 |
) |
Net cash used in operating activities
|
|
|
(333,692 |
) |
|
|
(163,541 |
) |
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
|
|
|
|
|
Purchase of equipment
|
|
|
(877 |
) |
|
|
(199,328 |
) |
Net cash used in investing activities
|
|
|
(877 |
) |
|
|
(199,328 |
) |
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
|
|
|
|
Proceeds from sale of common stock
|
|
|
- |
|
|
|
100,000 |
|
Proceeds from sale of common stock - related party
|
|
|
100,000 |
|
|
|
- |
|
Proceeds from loans
|
|
|
213,101 |
|
|
|
351,200 |
|
Repayment of loans
|
|
|
(53,480 |
) |
|
|
(136,709 |
) |
Proceeds from related party loans
|
|
|
172,500 |
|
|
|
174,411 |
|
Repayments of related party loans
|
|
|
(136,411 |
) |
|
|
(100,000 |
) |
Net cash provided by financing activities
|
|
|
295,710 |
|
|
|
388,902 |
|
|
|
|
|
|
|
|
|
|
NET (DECREASE) INCREASE IN CASH AND RESTRICTED CASH
|
|
|
(38,859 |
) |
|
|
26,033 |
|
CASH AND RESTRICTED CASH AT BEGINNING OF YEAR
|
|
|
50,386 |
|
|
|
24,353 |
|
CASH AND RESTRICTED CASH AT END OF YEAR
|
|
$ |
11,527 |
|
|
$ |
50,386 |
|
|
|
|
|
|
|
|
|
|
CASH AND RESTRICTED CASH CONSIST OF THE FOLLOWING:
|
|
|
|
|
|
|
|
|
END OF YEAR
|
|
|
|
|
|
|
|
|
Cash
|
|
|
5,627 |
|
|
|
50,386 |
|
Restricted Cash
|
|
|
5,900 |
|
|
|
- |
|
|
|
$ |
11,527 |
|
|
$ |
50,386 |
|
SUPPLEMENTAL CASH FLOW INFORMATION:
|
|
|
|
|
|
|
|
|
NON-CASH FINANCING ACTIVITIES:
|
|
|
|
|
|
|
|
|
Common stock issued with loans
|
|
$ |
19,860 |
|
|
$ |
99,632 |
|
Common stock issued with related party loans
|
|
$ |
39,160 |
|
|
$ |
126,402 |
|
Common stock issued for conversion of loans payable
|
|
$ |
225,000 |
|
|
$ |
- |
|
Common stock issued for conversion of related party loans
|
|
$ |
250,000 |
|
|
$ |
- |
|
Warrants issued with loans
|
|
$ |
99,364 |
|
|
$ |
20,717 |
|
Warrants issued with related party loans
|
|
$ |
67,940 |
|
|
$ |
- |
|
Warrants issued in lieu of deferred compensation
|
|
$ |
- |
|
|
$ |
250,000 |
|
Purchase of assets and settlement of accrued expenses through
issuance of loan payable
|
|
$ |
- |
|
|
$ |
140,188 |
|
Right-of-use assets obtained in exchange for liabilities
|
|
$ |
- |
|
|
$ |
267,704 |
|
|
|
|
|
|
|
|
|
|
CASH PAID FOR:
|
|
|
|
|
|
|
|
|
Interest
|
|
$ |
111,351 |
|
|
$ |
137,519 |
|
Income taxes
|
|
$ |
- |
|
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated
financial statements.
|
NOTE 1 – BUSINESS SUMMARY OF SIGNIFICANT
ACCOUNTING PRINCIPLES AND LIQUIDITY
Nature of
Business
First Foods Group, Inc. (the “Company” or “First Foods”) is a
smaller reporting company focused on developing its specialty
chocolate product line through its Holy Cacao subsidiary,
participating in merchant cash advances (“MCAs”) through its
1st Foods Funding Division, and introducing new
health-related brands, concepts and products through its FFGI
Wholesaling Division.
Holy Cacao is a majority owned subsidiary that is dedicated to
producing, packaging, distributing and selling specialty chocolate
products, including specialty chocolate products infused with a
hemp-based ingredient in accordance with the Company’s
understanding of the Agricultural Act of 2014 (the “2014 Farm
Bill”) and/or the Agriculture Improvement Act of 2018 (the “2018
Farm Bill,” and together with the 2014 Farm Bill, collectively, the
“Farm Bill”), which renders the production of hemp in compliance
with the provisions of the Farm Bill federally lawful. The Company
has not been, is not, and has no current plans to be involved in
producing, packaging, distributing or selling any product that is
infused with a marijuana-based ingredient, although it intends to
revisit the matter as regulations change in jurisdictions in which
it operates.
The Company is also dedicated to licensing its intellectual
property (“IP”), including its name, brand, and packaging, to third
parties. The Company may license its IP to third parties that may
produce, package, and distribute hemp-based products pursuant with
the Company’s understanding of the Farm Bill. The Company may
license its IP to third parties that may produce, package, and
distribute marijuana-based products, but only as such licensing is
legal. Holy Cacao holds four trademarks for the brands, “The
Edibles Cult”, “Purely Irresistible”, “Mystere” and “Southeast
Edibles”.
The Company also has a contract with TIER Merchant Advances LLC
(“TIER”) to participate in the purchase of future receivables from
qualified TIER merchants for the purpose of generating revenue for
the Company. The Company also provides cash advances directly to
merchants.
Reclassification
Certain reclassifications have been made to the Company’s
consolidated financial statements for the period ended December 31,
2020 to conform to the current period’s consolidated financial
statement presentation. Approximately $465,500 worth of related
party payables were reclassed to its own line item to conform with
current period presentation. There was no effect on total assets,
equity or net loss.
Liquidity and Going
Concern
The Company’s consolidated financial statements are prepared using
generally accepted accounting principles in the United States of
America (“GAAP”) applicable to a going concern which contemplates
the realization of assets and liquidation of liabilities in the
normal course of business. The Company has not yet established an
ongoing source of revenues sufficient to cover its operating costs
and allow it to continue as a going concern. The ability of the
Company to continue as a going concern is dependent on the Company
obtaining adequate capital to fund operating losses until it
becomes profitable. If the Company is unable to obtain adequate
capital, it could be forced to cease operations.
In order to continue as a going concern, the Company will need,
among other things, additional capital resources. As of December
31, 2021, the Company had approximately $1,337,000 in third-party
short-term debt and approximately $49,000 in associated debt
discount and approximately $490,000 in related-party short-term
debt and approximately $19,000 in associated debt discount that is
due within the next twelve months. Management’s plan is to continue
to increase revenue, obtain such resources for the Company by
obtaining capital from management and significant shareholders
sufficient to meet its operating expenses and seeking equity and/or
debt financing. However, neither any members of management nor any
significant shareholders are currently committed to invest funds
with us and; therefore, we cannot provide any assurances that the
Company will be successful in accomplishing any of its plans.
The Company does not have sufficient cash flow for the next twelve
months from the date of this report. The ability of the Company to
continue as a going concern is dependent upon its ability to
successfully accomplish the plans described in the preceding
paragraph and eventually secure other sources of financing and
attain profitable operations. The accompanying consolidated
financial statements do not include any adjustments that might be
necessary if the Company is unable to continue as a going
concern.
Use of Estimates
The preparation of consolidated financial statements in conformity
with GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the
consolidated financial statements and the reported amounts of
revenues and expenses during the reporting period. Actual results
could differ from those estimates.
Basis of
Presentation
The Company’s consolidated financial statements are presented in
accordance with generally accepted accounting principles in the
United States of America (“GAAP”).
The noncontrolling interest represents the proportionate share of
the proceeds received and also the income and loss pickup from the
fifteen-percent sale of equity interest in our 85% owned
subsidiary; Holy Cacao.
Principles of
Consolidation
The consolidated financial statements represent the consolidation
of the accounts of the Company and its subsidiary in conformity
with GAAP. All intercompany accounts and transactions have been
eliminated in consolidation.
Cash and Cash
Equivalents
The Company considers all highly liquid temporary cash investments
with an original maturity of twelve months or less to be cash
equivalents. At December 31, 2021 and 2020, the Company had no cash
equivalents.
The Company’s cash is held with financial institutions, and the
account balances may exceed the Federal Deposit Insurance
Corporation (FDIC) insurance limit at times. Accounts are insured
by the FDIC up to $250,000 per financial institution. The Company
has not experienced any losses in such accounts with these
financial institutions.
Restricted Cash
As of December 31, 2021 restricted cash included $5,900, which was
restricted pursuant to the requirements in the sales consultant
agreement entered into November 2020 (see note 8).
Merchant Cash
Advances
The Company participates in the merchant cash advance industry by
directly advancing sums to a merchant or a merchant advance
provider, TIER, who in turn advances sums to merchants or other
merchant cash advance providers. Each reporting period, the Company
reviews the carrying value of these advances and determines whether
an impairment reserve is necessary. At December 31, 2021, the
Company reserved an amount equal to 78% of the outstanding merchant
cash advance balance at period end based on the potential impact of
COVID 19.
Revenue
Recognition
We completed, related to our merchant cash advance business line,
our assessment of the impact of Accounting Standards Codification
(“ASC”) 606 and determined that we recognize revenue in accordance
with ASC 860, Transfers and Servicing, which is explicitly
excluded from the scope of ASC 606. We participate in the servicing
of merchant cash advances that have been provided to third parties,
which in accordance with ASC 860, causes us to recognize merchant
cash advance (“MCA”) income. We also have product sales from our
Holy Cacao division that follow ASC 606.
Product sales are measured based on consideration specified in a
contract with a customer that we expect to receive in exchange for
goods, net of any variable considerations (e.g. rights to return
product, sales incentives, etc.). The Company recognizes revenue
when it satisfies a performance obligation by transferring control
of a product to a customer. These criteria are assumed to have been
met upon delivery of the products requested by the customer to the
customer’s carrier. The Company applied the practical expedient
available under ASC 606 to disregard determining significant
financing components, if the good is transferred and payment is
received within one year.
When a merchant cash advance is purchased, the Company records a
merchant cash advance participation receivable for the purchase
price. The purchase price consists of the merchant cash advance
principal plus an up-front commission that is amortized over the
term of the merchant cash advance. The amount of the commission is
negotiated between the Company and TIER for each contract. The
standard commission is 15% of the merchant cash advance principal
but can be reduced depending upon the credit worthiness of the
merchant. The average commission paid by the Company since
inception has been approximately 7%. If a merchant cash advance
contract is signed in one period, but not paid until a subsequent
period, a corresponding liability is established in the current
period.
At the time the Company participates in a merchant cash advance,
the Company records a deferred revenue liability, which is the
total future receivable due to the Company less the principal
amount of the merchant cash advance. Revenue is recognized and the
deferred liability is reduced over the term of the merchant cash
advance.
TIER maintains a bank account on behalf of the Company. Each day,
TIER receives payment, reflected in the bank account, for each
merchant cash advance TIER has purchased on behalf of the Company
from various merchant cash advance providers. The Company reduces
its merchant cash advance balance by the cash received, which is
net of platform fees. Platform fees are a daily charge associated
with the ACH service and the financial and reporting management
software platform provided by TIER. The platform fees are also
negotiated between the Company and TIER for each contract but are
typically 4% of the daily merchant cash advance principal
amount.
For each merchant cash advance entered into by the Company, TIER
receives a daily payment as payments are made on the advance, for
each merchant cash advance TIER has purchased on behalf of the
Company from various merchant cash advance providers. The Company
reduces its merchant cash advance balance by the cash received,
which is net of a 2% commission to TIER.
The following table shows net sales by category for 2021 and
2020:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
|
Change
|
|
|
2020
|
|
Net sales by category:
|
|
|
|
|
|
|
|
|
|
Chocolate products
|
|
$ |
94,387 |
|
|
|
93 |
% |
|
$ |
48,983 |
|
Wholesale products
|
|
|
228,697 |
|
|
|
100 |
% |
|
|
- |
|
Merchant cash advances
|
|
|
39,673 |
|
|
|
-75 |
% |
|
|
159,184 |
|
Total net sales
|
|
$ |
362,757 |
|
|
|
74 |
% |
|
$ |
208,167 |
|
Accounts Receivable and
Allowance for Doubtful Accounts
Accounts receivable are carried at original invoice amount less an
estimate made for doubtful accounts based on a review of all
outstanding amounts. Management determines the allowance for
doubtful accounts by regularly evaluating individual customer
receivables and considering a customer’s financial condition,
credit history and current economic conditions and sets up an
allowance for doubtful accounts when collection is uncertain.
Customers’ accounts are written off when all attempts to collect
have been exhausted. The Company considers an invoice past due once
the term of the invoice has passed and payment has not been
received. No interest is charged on past due invoices. Recoveries
of accounts receivable previously written off are recorded as
income when received. As of December 31, 2021, the Company had no
allowance for doubtful accounts.
Inventory
Inventory, consisting of raw materials, work in process and
products available for sale, are accounted for using the first-in,
first-out method, and are valued at the lower of cost or net
realizable value. This valuation requires management to make
judgements based on currently available information, about the
likely method of disposition, such as through sales to individual
customers and returns. The Company has no allowance for inventory
reserves.
Inventory consisted of the following as of December 31, 2021 and
2020:
|
|
December 31,
|
|
|
December 31,
|
|
|
|
|
2021
|
|
|
|
2020
|
|
Raw Materials
|
|
$ |
40,080 |
|
|
$ |
37,259 |
|
Work in Process
|
|
|
8,965 |
|
|
|
2,790 |
|
Finished Goods
|
|
|
7,891 |
|
|
|
6,191 |
|
Total
|
|
$ |
56,936 |
|
|
$ |
46,240 |
|
Property and
Equipment
Property and equipment are stated at cost, less accumulated
depreciation and amortization. Expenditures for maintenance and
repairs are charged to expense when incurred, while renewals and
betterments that materially extend the life of an asset are
capitalized. When assets are sold, retired or otherwise disposed
of, the cost and accumulated depreciation are removed from the
balance sheets and any resulting gain or loss is reflected in the
consolidated statements of operations and members’ deficit in the
period realized.
Depreciation and amortization are provided using the straight-line
method over the estimated useful lives of the assets, which are as
follows:
Property – Leasehold improvements
|
|
4 years
|
|
Equipment
|
|
5 years
|
|
Impairment of Long-Lived
Assets
Long-lived assets are comprised of property and equipment. The
Company evaluates its long-lived assets for impairment whenever
events or changes in circumstances indicate the carrying value of
an asset or group of assets may not be recoverable. If these
circumstances exist, recoverability of assets to be held and used
is measured by a comparison of the carrying amount of an asset
group to future undiscounted net cash flows expected to be
generated by the asset group. If such assets are considered to be
impaired, the impairment to be recognized is measured by the amount
by which the carrying amount of the assets exceeds the fair value
of the assets. During the year ended December 31, 2021, the Company
impaired property and equipment for a total of $46,368. There
were no impairments to long-lived assets for the year ended
December 31, 2020.
Leases
The Company determines if an arrangement is a lease at the
inception of a contract. Operating lease right-of-use (“ROU”)
assets are included in right-of-use assets on the consolidated
balance sheets. The current and long-term components of operating
lease liabilities are included in the operating lease liabilities
and operating lease liabilities – long term, respectively on the
consolidated balance sheets.
Operating lease ROU assets and operating lease liabilities are
recognized based on the present value of the future minimum lease
payments over the lease term. As most of the Company’s leases do
not provide an implicit rate, the Company uses an incremental
borrowing rate based on the information available at the
commencement date in determining the present value of future
payments. Certain leases may include options to extend or terminate
the lease. Lease expense for minimum lease payments is recognized
on a straight-line basis over the lease term. Leases with an
initial term of 12 months or less are not recorded in the
consolidated balance sheet.
The company does not include the non-lease components that are
associated with the lease and accounts for them outside of the
lease in accordance with ASC Topic 842 Leases. The percentage of
cost associated with the lease component was 100%.
Research and
Development
The Company’s policy is to engage market and branding consultants
to research and develop specialty chocolate products, including
chocolate products infused with a hemp-based ingredient, and
packaging targeted to particular states within the US. The research
and development costs for the year ended December 31, 2021 and
2020, were approximately $89,000 and $87,000, respectively. These
expenses are included in general and administrative expenses on the
accompanying consolidated statements of operations.
Deferred Financing
Costs
The Company records origination and other expenses related to its
debt obligations as deferred financing costs. These expenses are
deferred and amortized over the life of the related debt
instrument. In accordance with Accounting Standards Update (“ASU”)
No. 2015-03, deferred finance costs, net of accumulated
amortization have been included as a contra to the corresponding
loans in the accompanying consolidated balance sheets as of
December 31, 2021 and 2020, respectively.
Stock Based
Compensation
The Company measures and recognizes compensation expense for all
stock-based payments at fair value over the requisite service
period. The Company uses the Black-Scholes option pricing model to
determine the weighted average fair value of options and warrants.
For restricted stock grants, fair value is determined as the
closing price of our common stock on the date of grant.
Equity-based compensation expense is recorded in administrative
expenses based on the classification of the employee or vendor. The
determination of fair value of stock-based payment awards on the
date of grant using an option-pricing model is affected by our
stock price, as well as by assumptions regarding a number of
subjective variables. These variables include, but are not limited
to, the expected stock price volatility over the term of the
awards, and actual and projected employee stock option exercise
behaviors.
Income Taxes
The Company provides for income taxes using the asset and liability
approach. Deferred tax assets and liabilities are recorded based on
the differences between the financial statement and tax bases of
assets and liabilities and the tax rates in effect when these
differences are expected to reverse. Deferred tax assets are
reduced by a valuation allowance if, based on the weight of
available evidence, it is more likely than not that some or all of
the deferred tax assets will not be realized. As of December 31,
2021 and 2020, the Company had a full valuation allowance against
deferred tax assets. With the historical change in ownership, the
Company is subject to certain NOL limitations under Section 382 of
the Internal Revenue Code.
Per Share Data
In accordance with “ASC-260 - Earnings per Share”, the basic loss
per common share is computed by dividing net loss available to
common stockholders by the weighted average number of common shares
outstanding. Diluted loss per common share is computed similar to
basic loss per common share except that the denominator is
increased to include the number of additional common shares that
would have been outstanding if the potential common shares had been
issued and if the additional common shares were dilutive. There
were no dilutive shares outstanding as of December 31, 2021 and
2020 because their effect would be antidilutive.
The Company had 5,704,775 and 4,899,750 warrants to purchase common
stock outstanding at December 31, 2021 and 2020, respectively. The
Company had 4,470,000 warrants to purchase Series B preferred stock
outstanding at December 31, 2021 and 2020. The Company has
outstanding one (1) Series A preferred share that is convertible
into five (5) shares of the Company’s common stock outstanding at
December 31, 2021 and 2020. Additionally, the Company has 354,999
Series B preferred shares, and 660,000 Series C preferred shares
outstanding that are convertible into 1,774,995 and 660,000 shares
of common stock, respectively, at December 31, 2021 and 2020,
respectively. The warrants and preferred stock were not included in
the Company’s weighted average number of common shares outstanding
because they would be anti-dilutive.
Fair Value of Financial
Instruments
Fair value estimates of financial instruments are made at a
specific point in time, based on relevant information about
financial markets and specific financial instruments. As these
estimates are subjective in nature, involving uncertainties and
matters of significant judgment, they cannot be determined with
precision. Changes in assumptions can significantly affect
estimated fair value. The carrying value of cash, merchant cash
advances, accounts receivable, vendor deposits, prepaid expenses,
accounts payable and accrued liabilities approximate their fair
value because of the short-term nature of these instruments.
Management is of the opinion that the Company is not exposed to
significant market or credit risks arising from these financial
instruments.
Advertising and
Promotion
Advertising and promotion costs are expensed as incurred.
Advertising and promotion costs for the year ended December 31,
2021 and 2020, were approximately $112,000 and $35,000,
respectively. These expenses are included in general and
administrative expenses on the accompanying consolidated statements
of operations.
Non-Controlling Interests
in Condensed Consolidated Financial Statements
In June 2011, the Financial Accounting Standards Board (“FASB”)
issued ASC 810-10-65-1, to clarify that a non-controlling
(minority) interest in a subsidiary is an ownership interest in the
entity that should be reported as equity in the consolidated
financial statements. It also requires consolidated net income to
include the amounts attributable to both the parent and
non-controlling interest, with disclosure on the face of the
consolidated income statement of the amounts attributed to the
parent and to the non-controlling interest. In accordance with ASC
810-10-45-21, those losses attributable to the parent and the
non-controlling interest in subsidiaries may exceed their interests
in the subsidiary’s equity. The excess and any further losses
attributable to the parent and the non-controlling interest shall
be attributed to those interests even if that attribution results
in a deficit non-controlling interest balance. During the year
ended December 31, 2017, the Company entered into a subscription
agreement for the sale of a ten-percent equity interest in its then
wholly owned subsidiary, Holy Cacao, for $200,000 in cash proceeds,
in the aggregate. During the year ended December 31, 2019, 5%
equity was issued to a service provider due to the completion of
Holy Cacao’s first sale of its product, as per the agreement with
the service provider. The Company’s periodic reporting now includes
the results of operations of Holy Cacao, with the fifteen-percent
ownership reported as non-controlling interests.
The following table summarizes the results of operations for Holy
Cacao for the period:
|
|
For The Year Ended
|
|
|
|
December 31,
|
|
|
|
|
2021
|
|
|
|
2020
|
|
Revenue
|
|
$ |
323,084 |
|
|
$ |
48,983 |
|
Cost of Goods Sold
|
|
|
(233,247 |
) |
|
|
(35,077 |
) |
Operating Expense
|
|
|
(705,216 |
) |
|
|
(511,963 |
) |
Impairment of Assets
|
|
|
(46,368
|
)
|
|
|
-
|
|
Loss from Operations
|
|
$ |
(661,747 |
) |
|
$ |
(498,057 |
) |
The Company conducts business as two operating segments, First
Foods and Holy Cacao. The Company does not distinguish between the
two segments and has only one reportable segment based on
quantitative thresholds. The accounting policies of the segments
are the same as the accounting policies of the Company as a whole.
The operating results of these business segments are regularly
reviewed by the Company’s chief operating decision maker.
Recent Accounting
Pronouncements
From time to time, new accounting pronouncements are issued by the
FASB or other standard setting bodies. Unless otherwise discussed,
the Company believes that the impact of recently issued standards
that are not yet effective will not have a material impact on its
consolidated financial position or results of operations upon
adoption.
In June 2016, the FASB issued ASU 2016-13, “Financial Instruments –
Credit Losses” to improve information on credit losses for
financial assets and net investment in leases that are not
accounted for at fair value through net income. ASU 2016-13
replaces the current incurred loss impairment methodology with a
methodology that reflects expected credit losses. In April 2019 and
May 2019, the FASB issued ASU No. 2019-04, “Codification
Improvements to Topic 326, Financial Instruments-Credit Losses,
Topic 815, Derivatives and Hedging, and Topic 825, Financial
Instruments” and ASU No. 2019-05, “Financial Instruments-Credit
Losses (Topic 326): Targeted Transition Relief” which provided
additional implementation guidance on the previously issued ASU. In
November 2019, the FASB issued ASU 2019-10, “Financial Instruments
- Credit Loss (Topic 326), Derivatives and Hedging (Topic 815), and
Leases (Topic 842),” which defers the effective date for public
filers that are considered small reporting companies (“SRC”) as
defined by the Securities and Exchange Commission to fiscal years
beginning after December 15, 2022, including interim periods within
those fiscal years. Since the Company is an SRC, implementation is
not needed until January 1, 2023. The Company will continue to
evaluate the effect adopting ASU 2016-13 will have on the Company’s
consolidated financial statements.
In May 2021, the FASB issued ASU 2021-04, “Earnings Per Share
(Topic 260), Debt - Modifications and Extinguishments (Subtopic
470-50), Compensation - Stock Compensation (Topic 718), and
Derivatives and Hedging – Contracts in Entity’s Own Equity
(Subtopic 815-40): Issuer’s Accounting for Certain Modifications or
Exchanges of Freestanding Equity – Classified Written Call Options
(a consensus of the FASB Emerging Issues Task Force).” The ASU
addresses how an issuer should account for modifications or an
exchange of freestanding written call options classified as equity
that is not within the scope of another Topic. For both public and
private companies, the ASU is effective for fiscal years beginning
after December 15, 2021. Transition is prospective. Early adoption
is permitted. The Company does not expect the adoption of ASU
2021-04 to have a material impact on its consolidated financial
statements.
NOTE 2 – RELATED PARTY TRANSACTIONS
Employment
Agreement
On March 1, 2017, Mark J. Keeley assumed the role of Chief
Financial Officer (“CFO”). Pursuant to his Employment Agreement,
the CFO shall receive $20,833 per month. Additionally, Mr. Keeley
earns an additional $40,000 per year for his role as a Director of
the Board. As of December 31, 2021 and 2020, the Company has
accrued $579,167 and $329,167, respectively, in relation to the
employment agreements and $24,203 and $20,578, respectively, in
relation to the payroll tax liability.
Consulting
Agreements
On February 27, 2017, Harold Kestenbaum assumed the role of
Chairman of the Board of Directors and Interim Chief Executive
Officer (“Interim CEO”). Mr. Kestenbaum earned $40,000 per year for
his role as Chairman of the Board and no longer takes compensation.
As of December 31, 2021, the Company has accrued a total of $40,000
of compensation for his role as Interim CEO under a previous
agreement.
As of December 31, 2021, the Company has a consulting agreement
with R and W Financial (a company owned by a director) for $5,000 a
month. The agreement is for an indefinite period of time and is
subject to cancellation by either party with written notice of 30
days. The outstanding balance as of December 31, 2021 and 2020 was
$146,303 and $82,988, respectively.
Related Party
Loans
|
|
|
|
|
|
|
December 31,
2021
|
|
|
December 31,
2020
|
|
|
1. |
|
|
Note payable at 12%, matures 4/17/2022.
|
|
{a} *
|
|
$ |
100,000 |
|
|
$ |
100,000 |
|
|
2. |
|
|
Non-interest bearing note payable, matures on 4/24/2022.
|
|
{b} *
|
|
|
179,813 |
|
|
|
179,813 |
|
|
3. |
|
|
Note payable at 12%, matures 4/22/2022. The Company has recorded
debt discount and amortized it over the applicable life of the
debt.
|
|
{c} *
|
|
|
100,000 |
|
|
|
100,000 |
|
|
4. |
|
|
Note payable at 12%, matured and converted into common stock on
5/10/2021.
|
|
{d} *
|
|
|
- |
|
|
|
250,000 |
|
|
5. |
|
|
Non-interest bearing note payable, matured & repaid on
1/05/2021. In connection with the issuance, the Company had
recorded debt discount and amortized it over the applicable life of
the debt.
|
|
*
|
|
|
- |
|
|
|
74,411 |
|
|
6. |
|
|
Non-interest bearing note payable, matures on 9/15/2022.
|
|
{e} *
|
|
|
500 |
|
|
|
- |
|
|
7. |
|
|
Non-interest bearing note payable, matures 4/22/2022. The Company
has recorded debt discount and amortized it over the applicable
life of the debt.
|
|
{f} *
|
|
|
50,000 |
|
|
|
- |
|
|
8. |
|
|
Non-interest bearing note payable, matures 5/30/2022.
|
|
{g} *
|
|
|
60,000 |
|
|
|
- |
|
|
|
|
|
Unamortized debt discount
|
|
|
|
|
(19,304 |
) |
|
|
(18,945 |
) |
|
|
|
|
Total
|
|
|
|
$ |
471,009 |
|
|
$ |
685,279 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
{a} - On October 17, 2021, the Company extended the note to April
17, 2022 based on the same terms and conditions.
|
|
|
|
|
{b} - On April 24, 2021, the Company extended the note to April 24,
2022 based on the same terms and conditions.
|
|
|
|
|
{c} - On October 25, 2021, the Company extended the note to April
22, 2022 based on the same terms and conditions. In association
with this and prior extensions the company issued 80,000 shares of
common stock with a fair value of $16,000, and 200,000 warrants
with a fair value of $31,550 which will be recorded as a debt
discount and amortized over the life of the loan. The warrants are
valued based on the Black Scholes Model, are fully vested as of the
issue date and have an exercise term of three (3) years.
|
|
|
|
|
{d} - On May 10, 2021, the loan was converted into 2,000,000 shares
of common stock. Additionally, the company granted warrants for the
right to purchase 375,000 shares of common stock at an exercise
price of $0.23 a share. The warrants are valued at $83,513 based on
the Black Scholes Model, are fully vested as of the issue date and
have an exercise term of three (3) years. In association with the
conversion of the note to common stock and warrants, the company
recognized a loss of $293,513.
|
|
|
|
|
{e} - On March 16, 2022, the Company extended the note to September
15, 2022 based on the same terms and conditions.
|
|
|
|
|
{f} - On April 29, 2021, the Company issued a non-interest bearing
promissory note of $50,000. In connection with this note the
company issued 50,000 shares of common stock with a fair value of
$10,500, which was recorded as a debt discount and amortized over
the life of the loan. The loans original maturity date was May 31,
2021 but has been extended to April 22, 2022. In association with
this and prior extensions the company granted warrants for the
right to purchase 200,000 shares of common stock with a fair value
of $36,410 based on the Black Scholes Model, are fully vested as of
the issue date and have an exercise term of three (3) years. The
Company recorded a debt discount and will amortize it over the life
of the loan.
|
|
|
|
|
{g} - On March 30, 2022, the Company extended the note to May 30,
2022 based on the same terms and conditions.
|
|
|
|
|
* - unsecured note
|
During the year ended December 31, 2021 and 2020, the Company
recorded $106,741 and $116,648 of interest expense related to the
amortization of debt discount and $34,356 and $54,148 of regular
interest, respectively.
As of December 31, 2021 and 2020, accrued interest was $68,149 and
$45,889, respectively.
During the year ended December 31, 2021, the Company converted
$250,000 of loan payable in exchange for 2,000,000 shares of common
stock and warrants for the right to purchase 375,000 shares of
common stock. The aggregate fair value of the common stock shares
issued and for the granted warrants was $543,513. The Company
recorded a loss on extinguishment of loans payable of $293,513.
Related Party
Payables
As of December 31, 2021, the Company owes a Director $150,822 for
expenses incurred on behalf of the company.
All of the above and below transactions were approved by
disinterested directors.
Director
Agreements
On May 10, 2018, the directors of the Company were awarded
share-based compensation for the service period of May 10, 2018
through December 31, 2020, as a one-time award of the ability to
purchase a particular amount of warrants, ranging from 80,000 to
400,000 (collectively the “Warrants”) before December 31, 2027.
The Company issued warrants with respect to 1,280,000 Series B
Preferred Stock, in the aggregate. The Company expensed the fair
value of these warrants in the amount of $768,000 ratably during
the years ended December 31, 2018, 2019 and 2020. There was no
expense related to these warrants for the year ended December 31,
2021. For the year ended December 31, 2020, the Company recorded
$290,981 as compensation expense related to the warrants.
On January 1, 2020, the Company entered into director agreements
with each of the Directors of the Company. Pursuant to the
agreements, each Director may be compensated with share-based
and/or cash-based compensation. The Directors’ compensation for the
period January 1, 2020 through December 31, 2020 was $10,000 per
quarter per Director to be paid on a date determined by the Board
of Directors. In addition, the Directors were able to receive a
one-time award of the ability to purchase a particular amount of
warrants, as determined by the Board of Directors. On January 1,
2021 and 2022, the director agreements were renewed with the same
terms. During the year ended December 31, 2021, a director agreed
to waive 118,333 of preferred B shares of stock and $110,000 of
accrued director compensation. The company recorded the forgiveness
of accrued director compensation as other income. As of December
31, 2021 and 2020 the Company has accrued approximately $381,000
and $320,000, respectively, in relation to the director
agreements.
On July 7, 2020, our Board of Directors appointed Michael Kaplan to
the Board of Directors.
Mr. Kaplan’s compensation as a director for the initial twelve
months will consist of one million (1,000,000) warrants which will
vest at the rate of 83,333 warrants per month for the initial
eleven months and the balance in the twelfth month, provided he is
a director on each vesting date, with the initial tranche vesting
on the day he takes office and then on each monthly anniversary of
such date thereafter. Each Warrant will be exercisable for 36
months after it vests and will be exercisable at a price of $0.18
per share. The warrants are valued at $177,200 based on the Black
Scholes Model. If he remains in office beyond twelve months,
commencing with month thirteen, his compensation will be similar to
the majority of the directors then in office. The company is
currently in negotiation with Mr. Kaplan regarding his
compensation, but he remains as an active unpaid director. For the
years ended December 31, 2021 and 2020, the Company recorded
$91,270 and $85,930 as compensation expense related to the
warrants, respectively.
Prior to Mr. Kaplan’s appointment to the Board of Directors, on
July 7, 2020 the Company entered into (i) a Subscription Agreement
with Mr. Kaplan to sell to him one million (1,000,000) shares of
common stock at a purchase price of $0.20 per share for a total
purchase price of $200,000, which shares shall be purchased in
twelve (12) equal monthly installments of 83,333 shares (the last
installment to cover 83,337 shares) with the initial purchase
occurring on the date thereof and subsequent installments on each
monthly anniversary thereafter (ii) a Consulting Agreement with Mr.
Kaplan to award him, as full compensation for two (2) years of
service, warrants to purchase two million (2,000,000) shares of
common stock at an exercise price of $0.18 per share, which was the
closing price of our common stock on such date. The warrants are
valued at $354,400 based on the Black Scholes Model; and (iii) an
arrangement with Mr. Kaplan that in the event he raises outside
investment in the Company in the amount of $500,000 - $2,000,000,
he will receive a warrant with one underlying share for each dollar
he so raises. For the years ended December 31, 2021 and 2020, the
Company recorded $168,340 and $99,353 as compensation expense
related to the warrants, respectively.
The warrants shall vest upon the occurrence to the Company of
certain milestone events through the efforts of the consultant.
(See Note 6).
If terminated with cause by the Company, the consultant shall not
thereafter be entitled to any form of compensation, the unvested
warrants shall terminate, and he shall be paid a buyout fee in the
amount of 250,000 fully vested warrants. If terminated without
cause by the Company, all unvested warrants shall be accelerated
and vest in one-half the time it was previously scheduled to
vest.
NOTE 3 – PROPERTY AND EQUIPMENT
Property and equipment, net consists of the following:
|
|
|
December 31,
2021
|
|
|
|
December 31,
2020
|
|
Leasehold improvements
|
|
$ |
33,000 |
|
|
$ |
40,000 |
|
Equipment
|
|
|
201,024 |
|
|
|
239,515 |
|
Less: Accumulated depreciation and amortization
|
|
|
(94,921 |
) |
|
|
(37,077 |
) |
Total
|
|
$ |
139,103 |
|
|
$ |
242,438 |
|
NOTE 4 – ACCOUNTS PAYABLE, RELATED PARTY PAYABLE AND
ACCRUED LIABILITIES
Accounts payable and accrued liabilities consist of the
following:
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2021
|
|
|
2020
|
Accounts Payable |
|
$ |
221,206 |
|
|
$ |
146,910 |
|
Interest |
|
|
209,311 |
|
|
|
109,747 |
|
Salaries |
|
|
603,371 |
|
|
|
349,745 |
|
Other |
|
|
40,328 |
|
|
|
38,690 |
|
Total third party payables |
|
|
1,074,216 |
|
|
|
645,092 |
|
Related party payables, officers
and director fees |
|
|
718,114 |
|
|
|
465,506 |
|
Total payables |
|
$ |
1,792,330 |
|
|
$ |
1,110,598 |
|
NOTE 5 – LOANS AND LONG-TERM LOANS
|
|
|
|
|
|
|
December 31,
2021
|
|
|
December 31,
2020
|
|
|
1. |
|
|
Note payable at 12%, matures 4/16/2022. In connection with the
original issuance, as well as subsequent extension, the Company has
recorded debt discount and amortized it over the applicable life of
the debt.
|
|
{a} *
|
|
$ |
50,000 |
|
|
$ |
50,000 |
|
|
2. |
|
|
Note payable at 12%, matures 4/22/2022. In connection with the
original issuance, as well as subsequent extension, the Company has
recorded debt discount and amortized it over the applicable life of
the debt.
|
|
{b} *
|
|
|
18,000 |
|
|
|
18,000 |
|
|
3. |
|
|
Note payable at 12%, matured and converted into common stock on
12/2/21.
|
|
{c} *
|
|
|
- |
|
|
|
50,000 |
|
|
4. |
|
|
Note payable at 12%, matured and converted into common stock on
6/19/2021.
|
|
{d} *
|
|
|
- |
|
|
|
25,000 |
|
|
5. |
|
|
Note payable at 12%, matures 6/30/2022. In connection with the
issuance, the Company has recorded debt discount and amortized it
over the applicable life of the debt.
|
|
{e} *
|
|
|
250,000 |
|
|
|
250,000 |
|
|
6. |
|
|
Note payable at 12%, matures 4/16/2022. In connection with the
issuance, the Company has recorded debt discount and amortized it
over the applicable life of the debt.
|
|
{f} *
|
|
|
410,000 |
|
|
|
410,000 |
|
|
7. |
|
|
Note payable at 12%, matures 4/16/2022. In connection with the
issuance, the Company has recorded debt discount and amortized it
over the applicable life of the debt.
|
|
{g} *
|
|
|
140,000 |
|
|
|
140,000 |
|
|
8. |
|
|
Note payable at 12%, matures 4/30/2022. In connection with the
issuance, the Company has recorded debt discount and amortized it
over the applicable life of the debt.
|
|
{h} *
|
|
|
200,000 |
|
|
|
200,000 |
|
|
9. |
|
|
Note payable at 12%, matures 7/31/2022. In connection with the
issuance, the Company has recorded debt discount and amortized it
over the applicable life of the debt.
|
|
{i} *
|
|
|
60,000 |
|
|
|
60,000 |
|
|
10. |
|
|
Note payable at 12%, matures 7/29/2022. In connection with the
issuance, the Company has recorded debt discount and amortized it
over the applicable life of the debt.
|
|
{j} *
|
|
|
96,000 |
|
|
|
96,000 |
|
|
11. |
|
|
Note payable at 3.75%, matures 6/25/2050 - Economic injury disaster
loan.
|
|
**
|
|
|
150,000 |
|
|
|
150,000 |
|
|
12. |
|
|
Non-interest bearing note payable, matured and repaid on
9/30/2021.
|
|
*
|
|
|
- |
|
|
|
53,479 |
|
|
13. |
|
|
Note payable at 12%, matured and converted into common stock on
10/25/21.
|
|
{k} *
|
|
|
- |
|
|
|
50,000 |
|
|
14. |
|
|
Note payable at 12.5%, matures 12/17/2022.
|
|
*
|
|
|
3,600 |
|
|
|
- |
|
|
15. |
|
|
Non-interest bearing note payable, matures 9/19/2022. In connection
with the issuance, the Company has recorded debt discount and
amortized it over the applicable life of the debt.
|
|
{l} *
|
|
|
16,500 |
|
|
|
- |
|
|
16. |
|
|
Non-interest bearing note payable, matures 4/16/2022.
|
|
{m} *
|
|
|
50,000 |
|
|
|
- |
|
|
17. |
|
|
Non-interest bearing note payable, matures 3/31/2022.
|
|
{n} ***
|
|
|
30,000 |
|
|
|
- |
|
|
18. |
|
|
Non-interest bearing note payable, matures 4/16/2022.
|
|
{o} *
|
|
|
13,000 |
|
|
|
- |
|
|
|
|
|
Unamortized debt discount
|
|
|
|
|
(48,514 |
) |
|
|
(286,300 |
) |
|
|
|
|
Total
|
|
|
|
|
1,438,586 |
|
|
|
1,266,179 |
|
|
|
|
|
Less: short term loans, net |
|
|
|
|
1,288,586 |
|
|
|
966,155 |
|
|
|
|
|
Total long-term loans, net |
|
|
|
$ |
150,000 |
|
|
$ |
300,024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
{a} - On August 4, 2021, the Company extended the note to January
23, 2022 based on the same terms and conditions. In association
with the extension the company granted warrants with the right to
purchase 50,000 shares of common stock with a fair value on $7,675,
which will be recorded as a debt discount and amortized over the
new life of the loan. The warrants are valued based on the Black
Scholes Model, are fully vested as of the issue date and have an
exercise term of three (3) years. On March 7, 2021, the Company
extended the note to April 16, 2022 based on the same terms and
conditions.
|
|
|
|
|
{b} - On August 4, 2021, the Company extended the note to October
22, 2021 based on the same terms and conditions. In association
with the extension the company issued 18,000 shares of common stock
with a fair value on $2,880, which will be recorded as a debt
discount and amortized over the new life of the loan. On October
14, 2021, the Company extended the note to April 22, 2022 based on
the same terms and conditions. In association with the extension
the company issued 18,000 shares of common stock with a fair value
of $2,700, which will be recorded as a debt discount and amortized
over the new life of the loan.
|
|
|
|
|
{c} - On December 2, 2021, the Company converted the entire value
of the note to 416,667 shares of common stock with a fair value of
$100,167. In association with the conversion of the note to common
stock, the company recognized a loss of $50,167.
|
|
|
|
|
{d} - On June 19, 2021, the Company converted the entire value of
the note to 191,424 shares of common stock with a fair value of
$31,260. In association with the conversion of the note to common
stock, the company recognized a loss of $6,260.
|
|
|
|
|
{e} - On August 6, 2021, the Company extended the note to January
31, 2022. The current interest rate will continue at 12% per annum,
however the amount of interest above a rate of 6% per annum will be
deemed paid by being added to capital due from the Company to the
creditor. This additional capital amount will not bear interest in
the period to January 31, 2022. In association with the extension
the company granted warrants with the right to purchase 250,000
shares of common stock with a fair value on $37,125, which will be
recorded as a debt discount and amortized over the new life of the
loan. On March 21, 2022, the Company extended the note to June 30,
2022. In association with the extension the company granted
warrants with the right to purchase 125,000 shares of common stock
with a fair value on $28,150, which will be recorded as a debt
discount and amortized over the new life of the loan. The warrants
are valued based on the Black Scholes Model, are fully vested as of
the issue date and have an exercise term of three (3) years.
|
|
|
|
|
{f} - On October 28, 2021, the Company extended the note to April
2, 2022 based on the same terms and conditions. In association with
the extension the company modified previously granted warrants by
lowering the exercise price to $0.17 and extending the expiration
date of the warrants by three (3) years. The value of the
modification of the warrants is $12,936, which will be recorded a
debt discount and amortized over the extension of the loan.
|
|
|
|
|
{g} - On October 28, 2021, the Company extended the note to April
16, 2022 based on the same terms and conditions. In association
with the extension the company modified previously granted warrants
by lowering the exercise price to $0.17 and extending the
expiration date of the warrants by three (3) years. The value of
the modification of the warrants is $23,173, which will be recorded
a debt discount and amortized over the extension of the loan.
|
|
|
|
|
{h} - On October 28, 2021, the Company extended the note to April
31, 2022 based on the same terms and conditions. In association
with the extension the company modified previously granted warrants
by lowering the exercise price to $0.17 and extending the
expiration date of the warrants by three (3) years. The value of
the modification of the warrants is $11,780, which will be recorded
a debt discount and amortized over the extension of the loan.
|
|
|
|
|
{i} - On August 4, 2021, the Company extended the note to January
23, 2022 based on the same terms and conditions. In association
with the extension the company issued 60,000 shares of common stock
with a fair value on $9,600, which will be recorded as a debt
discount and amortized over the new life of the loan. On March 16,
2022, the Company extended the note to July 31, 2022 based on the
same terms and conditions. In association with the extension the
company issued 60,000 shares of common stock with a fair value on
$12,600, which will be recorded as a debt discount and amortized
over the new life of the loan.
|
|
|
|
|
{j} - On October 28, 2021, the Company extended the note to July
29, 2022 based on the same terms and conditions. In association
with the extension the company modified previously granted warrants
by lowering the exercise price to $0.17 and extending the
expiration date of the warrants by three (3) years. The value of
the modification of the warrants is $3,878, which will be recorded
a debt discount and amortized over the extension of the loan.
|
|
|
|
|
{k} - On October 8, 2021, the Company converted the entire value of
the note to 333,556 shares of common stock with a fair value of
$55,570.
|
|
|
|
|
{l} - On September 20, 2021, the Company issued a non-interest
bearing note of $16,500. In connection with this note the company
granted warrants for the right to purchase 16,500 shares of common
stock at an exercise price of $0.18 a share. The warrants are
valued at $2,802 based on the Black Scholes Model, are fully vested
as of the issue date and have an exercise term of three (3) years.
The Company recorded a debt discount and will amortize it over the
life of the loan.
|
|
|
|
|
{m} - On February 23, 2022, the Company extended the note to March
16, 2022 based on the same terms and conditions. On March 10, 2022,
the Company extended the note to April 16, 2022 based on the same
terms and conditions.
|
|
|
|
|
{n} - On February 16, 2022, the Company extended the note to
March 31, 2022 based on the same terms and conditions. On March 25,
2022, the Company extended the note to April 16, 2022 based on the
same terms and conditions.
|
|
|
|
|
{o} - On February 16, 2022, the Company extended the note to
March 31, 2022 based on the same terms and conditions. On March 25,
2022, the Company extended the note to April 16, 2022 based on the
same terms and conditions.
|
|
|
|
|
* - unsecured note
|
|
|
|
|
**- secured note and collateralized by all tangible and intangible
personal property
|
|
|
|
|
*** - unsecured note and guaranteed by a Director of the
Company
|
During the years ended December 31, 2021 and 2020, the Company
recorded $357,010 and $383,338 of interest expense related to the
amortization of debt discount and $168,397 and $160,216 of regular
interest, respectively. As of December 31, 2021 and 2020, accrued
interest was $132,778 and $61,099, respectively.
As of December 31, 2021 and 2020, accrued interest associated with
the economic injury disaster loan was $8,385 and $2,759,
respectively.
NOTE 6 – STOCKHOLDERS’ DEFICIT
The following table shows the respective common stock issuances and
fair values for the years ending December 31, 2021 and 2020:
December 31, 2021
|
|
|
Shares
|
|
|
|
Amount
|
|
|
|
|
|
|
|
|
Common stock issued for cash to a related party
|
|
|
499,998 |
|
|
$ |
100,000 |
|
Stock compensation consultant – Put liability
|
|
|
147,991 |
|
|
$ |
- |
|
Common stock issued to consultants for services
|
|
|
70,856 |
|
|
$ |
9,432 |
|
Common stock issued for related party loan
|
|
|
190,000 |
|
|
$ |
39,160 |
|
Common stock issued with loans payable
|
|
|
114,000 |
|
|
$ |
19,860 |
|
Common stock issued for conversion of loans payable
|
|
|
1,608,314 |
|
|
$ |
343,997 |
|
Common stock issued for conversion of related party loans
payable
|
|
|
2,000,000 |
|
|
$ |
460,000 |
|
|
|
|
|
|
|
|
|
|
December 31, 2020
|
|
|
|
Shares
|
|
|
|
Amount
|
|
|
|
|
|
|
|
|
|
|
Common stock issued for cash to a related party
|
|
|
499,998 |
|
|
$ |
100,000 |
|
Common stock issued to consultants for services
|
|
|
600,000 |
|
|
$ |
131,350 |
|
Common stock issued with loans payable
|
|
|
374,000 |
|
|
$ |
99,632 |
|
Common stock issued for related party loans
|
|
|
579,410 |
|
|
$ |
126,402 |
|
Warrant Activity
Common Stock
Warrants
On January 29, 2020, the Company issued a promissory note of
$96,000 (see Note 5). In connection with this note the Company
issued warrants to purchase 96,000 shares of the Company’s common
stock with an exercise price of $0.22 per share. The warrants are
valued at $20,717 based on the Black Scholes Model and included in
the debt discount. The warrants are fully vested as of the issue
dates with an exercise term of three (3) years.
On July 7, 2020, our Board of Directors appointed Michael Kaplan to
the Board of Directors. Mr. Kaplan’s compensation as a director for
the initial twelve months will consist of one million (1,000,000)
warrants which will vest at the rate of 83,333 warrants per month
for the initial eleven months and the balance in the twelfth month,
provided he is a director on each vesting date, with the initial
tranche vesting on the day he takes office and then on each monthly
anniversary of such date thereafter. Each Warrant will be
exercisable for 36 months after it vests and will be exercisable at
a price of $0.18 per share. The warrants are valued at $177,200
based on the Black Scholes Model. For the years ended December 31,
2021 and 2020, the Company recorded $91,270 and $85,930 as
compensation expense related to the warrants, respectively.
Prior to Mr. Kaplan’s appointment to the Board of Directors, on
July 7, 2020 the Company entered into a Consulting Agreement with
Mr. Kaplan to award him, as full compensation for two (2) years of
service, warrants to purchase two million (2,000,000) shares of
common stock at an exercise price of $0.18 per share, which was the
closing price of our common stock on such date. The warrants are
valued at $354,400 based on the Black Scholes Model. Due to the
fact that management has assessed the probability of certain
milestones being met as probable, the warrants are being
straight-lined over the term of services, and accelerated whenever
a milestone is met. The probability of the remaining milestones
being met is reviewed by management every quarter. For the years
ended December 31, 2021 and 2020, the Company recorded $168,340 and
$99,353 as compensation expense related to the warrants,
respectively. The warrants shall vest upon the occurrence to the
Company of the following milestone events through the efforts of
the consultant:
No. of Warrants
|
|
|
Milestone
|
|
100,000
|
|
|
Acceptance by the Company of a full go-to market strategy for the
Company’s products. This milestone has been achieved as of December
31, 2021.
|
|
100,000
|
|
|
Acceptance by the Company of a social marketing platform and PR
strategy and onboarding of such.
|
300,000/500,000
|
|
|
300,000 for each multi outlet (“MULO”) retailer that is onboarded -
regardless of store count carrying the product; and 500,000, if the
onboarded MULO is a national chain.
|
|
300,000
|
|
|
Deliverance of full due diligence package for each potential
acquisition for which the Company requests the consultant perform
due diligence
|
|
500,000
|
|
|
Upon the closing of any acquisition which the consultant brought to
the Company and provided due diligence.
|
|
500,000
|
|
|
Additional compensation in board seat agreement.
|
On August 4, 2020, the Company signed an Employment Agreement for a
term of three years with an annual base salary of eighty four
thousand dollars ($84,000). As part of the agreement the Company
issued a warrant to the employee to purchase 300,000 shares of the
Company’s common stock with a term of three (3) years. The warrants
are valued at $97,470 based on the Black Scholes Model. In
addition, the employee will receive a warrant to purchase 300,000
of the Company’s common stock for each of the two remaining years
under the Employment Agreement with an exercise price equal to the
closing market price of the Company’s common stock on the first day
of each of such two annual employment periods. The warrants will be
subject to a 12-month period whereby the warrants will vest in
equal monthly increments for each year of the employment period.
Each of the warrants will be exercisable within a three-year period
from the date of issue. Once per quarter, the employee may waive
the right to receive 25,000 warrants and receive in exchange for
$5,000 worth of shares of the Company’s common stock. In the event
the employee’s employment is terminated by the Company without
cause, the employee shall be entitled to receive severance in an
amount equal to the lesser of three month’s salary or the amount of
salary otherwise payable until the termination date. The employee
additionally shall be entitled to retain all warrants scheduled to
vest within the following six months. For the years ended December
31, 2021 and 2020, the Company recorded $57,681 and $39,789 as
compensation expense related to the warrants, respectively. On
August 4, 2021, the Company granted the Employee warrants to
purchase up to 300,000 shares of common stock. The warrants are
valued at $46,050 based on the Black Scholes Model.
On November 9, 2020, the Company entered into a grant agreement
with a sales consultant (see Note 8). On September 30, 2021 and
June 29, 2021, the company granted the sales consultant warrants
for the right to purchase 17,801 and 39,474 shares of common stock
at an exercise price of $0.17 and $0.21 a share, respectively. The
warrants are valued at a total of $10,815 based on the Black
Scholes Model, are fully vested as of the issue date and have an
exercise term of three (3) years. As a result of this issuance, the
price protection clause on the director’s warrants issued on
December 31, 2019 and on the consultant’s warrant issued on July
31, 2020 and August 4, 2020, were triggered resulting in the
warrants being reset to an exercise price of $1.05 and $0.21,
respectively. As a result of the modification of the exercise price
of these warrants, the Company recognized an incremental value of
$337,930, for the year ended December 31, 2021, which was recorded
as a deemed dividend on the condensed consolidated statement of
operations.
On May 10, 2021, the Company converted a related party loan (see
Note 2). In association with the conversion the company issued
2,000,000 shares of common stock and granted warrants for the right
to purchase 375,000 shares of common stock at an exercise price of
$0.23 a share. The warrants are valued at $83,513 based on the
Black Scholes Model, are fully vested as of the issue date and have
an exercise term of three (3) years.
On June 30, 2021, the Company extended the maturity date on one of
its promissory notes (see Note 2). In association with this
extension the company granted warrants for the right to purchase
100,000 shares of common stock at an exercise price of $0.21 a
share. The warrants are valued at $20,200 based on the Black
Scholes Model, are fully vested as of the issue date and have an
exercise term of three (3) years. The Company recorded a debt
discount and will amortize it over the life of the loan.
On August 4, 2021, the Company extended the maturity date on one of
its promissory notes (see Note 2). In association with this
extension the company granted warrants for the right to purchase
100,000 shares of common stock at an exercise price of $0.16 a
share. The warrants are valued at $15,340 based on the Black
Scholes Model, are fully vested as of the issue date and have an
exercise term of three (3) years. The Company recorded a debt
discount and will amortize it over the life of the loan.
On August 4, 2021, the Company extended the maturity date on one of
its promissory notes (see Note 5). In association with this
extension the company granted warrants for the right to purchase
50,000 shares of common stock at an exercise price of $0.16 a
share. The warrants are valued at $7,675 based on the Black Scholes
Model, are fully vested as of the issue date and have an exercise
term of three (3) years. The Company recorded a debt discount and
will amortize it over the life of the loan.
On August 6, 2021, the Company extended the maturity date on one of
its promissory notes (see Note 5). In association with this
extension the company granted warrants for the right to purchase
250,000 shares of common stock at an exercise price of $0.16 a
share. The warrants are valued at $37,125 based on the Black
Scholes Model, are fully vested as of the issue date and have an
exercise term of three (3) years. The Company recorded a debt
discount and will amortize it over the life of the loan.
On September 20, 2021, the Company issued a promissory note of
$16,500 (see Note 5). In connection with this note the Company
issued warrants to purchase 16,500 shares of the Company’s common
stock with an exercise price of $0.18 per share. The warrants are
valued at $2,802 based on the Black Scholes Model and included in
the debt discount. The warrants are fully vested as of the issue
dates with an exercise term of three (3) years.
On October 25, 2021, the Company extended the maturity date on one
of its promissory notes (see Note 2). In association with this
extension the company granted warrants for the right to purchase
100,000 shares of common stock at an exercise price of $0.17 a
share. The warrants are valued at $16,210 based on the Black
Scholes Model, are fully vested as of the issue date and have an
exercise term of three (3) years. The Company recorded a debt
discount and will amortize it over the life of the loan.
On October 28, 2021, the Company extended the maturity date on one
of its promissory notes (see Note 2). In association with this
extension the company granted warrants for the right to purchase
100,000 shares of common stock at an exercise price of $0.17 a
share. The warrants are valued at $16,190 based on the Black
Scholes Model, are fully vested as of the issue date and have an
exercise term of three (3) years. The Company recorded a debt
discount and will amortize it over the life of the loan.
On November 9, 2020, the Company entered into a grant agreement
with a sales consultant (see Note 8). As compensation for the
services, the sales consultant shall be issued three million
(3,000,000) warrants to purchase shares. One warrant shall be fully
vested for every share issued. The exercise price of each warrant
shall be equal to the grant price and each warrant shall be
exercisable for thirty-six (36) months following the date of
vesting. Until such time as the shares underlying the warrants are
registered, the warrants may be exercised via a cashless exercise.
During the year ended December 31, 2021 the company issued warrants
with the right to purchase up to 57,275 shares of common stock as
compensation for services. As of December 31, 2021, there were
2,942,725 warrants remaining to be issued if certain performance
thresholds are met.
The Company utilized the Black-Scholes option-pricing model to
estimate fair value, utilizing the following assumptions for the
respective years:
|
|
|
2021
|
|
|
|
2020
|
|
Risk-free interest rate
|
|
|
0.03-0.08
|
%
|
|
|
0.10-1.39
|
%
|
Expected term of options, in years
|
|
|
3 |
|
|
|
3 |
|
Expected annual volatility
|
|
|
228.0-247.7
|
%
|
|
|
269.9-279.5
|
%
|
Expected dividend yield
|
|
|
—
|
%
|
|
|
—
|
%
|
Determined grant date fair value per option
|
|
$ |
0.14 - 0.22
|
|
|
|
$ 0.17 – 0.32
|
|
A summary of the Company’s warrants to purchase common stock
activity is as follows:
|
|
Number of
Warrants
(in common
shares)
|
|
|
Weighted
Average
Exercise
Price
|
|
Outstanding, December 31, 2019
|
|
|
1,403,750 |
|
|
$ |
0.26 |
|
Granted
|
|
|
3,496,000 |
|
|
|
0.20 |
|
Exercised
|
|
|
- |
|
|
|
- |
|
Forfeited or cancelled
|
|
|
- |
|
|
|
- |
|
Outstanding, December 31, 2020
|
|
|
4,899,750 |
|
|
$ |
0.21 |
|
Granted
|
|
|
1,148,775 |
|
|
|
0.19 |
|
Exercised
|
|
|
- |
|
|
|
- |
|
Forfeited or cancelled
|
|
|
(343,750 |
) |
|
|
0.08 |
|
Outstanding, December 31, 2021
|
|
|
5,704,775 |
|
|
$ |
0.22 |
|
As of December 31, 2021, 3,804,775 warrants for common stock were
exercisable and the intrinsic value of these warrants was $64,834,
the weighted average remaining contractual life for warrants
outstanding was 2.09 years and the remaining expense is $86,707
over the remaining amortization period which is 7 months.
Summary information regarding the options outstanding and
exercisable at December 31, 2021 is as
follows:
|
|
Outstanding
|
|
|
Exercisable
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
Weighted
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
Remaining
|
|
|
Average
|
|
|
|
|
|
Average
|
|
Range of
|
|
Number
|
|
|
Contractual
|
|
|
Exercise
|
|
|
|
|
|
Exercise
|
|
Exercise Prices
|
|
|
Outstanding
|
|
|
|
Life
|
|
|
Price
|
|
|
Exercisable
|
|
|
Price
|
|
|
|
(in shares)
|
|
|
(in years)
|
|
|
|
|
|
(in shares)
|
|
|
|
|
$0.16 – $0.50
|
|
|
5,704,775 |
|
|
|
2.09 |
|
|
$ |
0.22 |
|
|
|
3,804,775 |
|
|
$ |
0.24 |
|
As of December 31, 2020, 2,303,917 warrants for common stock were
exercisable and the intrinsic value of these warrants was $71,056,
the weighted average remaining contractual life for warrants
outstanding was 2.87 years and the remaining expense is $403,998
over the remaining amortization period which is 1.50 years
Preferred Stock
Warrants
On March 18, 2020, the Company issued its CFO and Director warrants
to purchase 500,000 shares of Series B Preferred Stock in lieu of
$250,000 of deferred salary. The warrants have an exercise price of
$0.75 per share, are fully vested at issuance, and are exercisable
from March 18, 2020 through March 17, 2030. The fair value of these
warrants was $375,000 and the additional $125,000 over the deferred
salary amount was recorded as compensation expense during the nine
months ended September 30, 2020. As a result of this issuance, the
price protection clause on the director’s warrants issued on
December 31, 2019 was triggered resulting in the warrants being
reset to an exercise price of $0.75, and the effect was
immaterial.
The Company utilized the Black-Scholes option-pricing model to
estimate fair value, utilizing the following assumptions for the
year ending 2020. There were no issuances in the year ending
2021.
|
|
2020
|
|
Risk-free interest rate
|
|
|
1.12 |
% |
Expected term of options, in years
|
|
|
10 |
|
Expected annual volatility
|
|
|
348.2 |
% |
Expected dividend yield
|
|
|
—
|
%
|
Determined grant date fair value per option
|
|
$ |
0.75 |
|
A summary of the Company’s warrants to purchase Series B Preferred
Stock activity is as follows:
|
|
Number of Warrants
(in Series B Preferred
Stock)
|
|
|
Weighted
Average
Exercise
Price
|
|
Outstanding, December 31, 2019
|
|
|
3,970,000 |
|
|
$ |
0.67 |
|
Granted
|
|
|
500,000 |
|
|
|
0.75 |
|
Outstanding, December 31, 2020
|
|
|
4,470,000 |
|
|
$ |
0.68 |
|
Granted
|
|
|
- |
|
|
|
- |
|
Exercised
|
|
|
- |
|
|
|
- |
|
Forfeited or cancelled
|
|
|
- |
|
|
|
- |
|
Outstanding, December 31, 2021
|
|
|
4,470,000 |
|
|
$ |
0.68 |
|
As of December 31, 2021, 4,470,000 warrants for Series B preferred
stock were exercisable and the intrinsic value of these warrants
was $1,758,600, the weighted average remaining contractual life for
warrants outstanding was 6.37 years.
Summary information regarding the options outstanding and
exercisable at December 31, 2021 is as
follows:
|
|
Outstanding
|
|
|
Exercisable
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
Weighted
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
Remaining
|
|
|
Average
|
|
|
|
|
|
Average
|
|
Range of
|
|
Number
|
|
|
Contractual
|
|
|
Exercise
|
|
|
Number
|
|
|
Exercise
|
|
Exercise Prices
|
|
Outstanding
|
|
|
Life
|
|
|
Price
|
|
|
Exercisable
|
|
|
Price
|
|
|
|
(in shares)
|
|
|
(in years)
|
|
|
|
|
|
(in shares)
|
|
|
|
|
$0.51 – $1.20
|
|
|
4,470,000 |
|
|
|
6.37 |
|
|
$ |
0.68 |
|
|
|
4,470,000 |
|
|
$ |
0.68 |
|
As of December 31, 2020, 4,470,000 warrants for Series B preferred
stock were exercisable and the intrinsic value of these warrants
was $1,932,750, the weighted average remaining contractual life for
warrants outstanding was 7.37 years and the warrants have been
fully expensed.
NOTE 7 – LEASES
On June 23, 2020, the Company entered into an operating lease
agreement with a term of 4 years, and an option to extend for three
years, comprising of office and warehouse space. This option is
included in the lease term when it is reasonably certain that the
option will be exercised and failure to exercise such option will
result in economic penalty and as such the option to extend for the
three-year term is not included in the below calculation.
For the years ended December 31, 2021 and 2020, the Company
incurred lease expense for its operating leases of $87,642 and
$43,821, respectively, which was included in general and
administrative expenses on the accompanying consolidated statements
of operations.
The Company’s weighted-average remaining lease term relating to its
operating leases is 2.33 years, with a weighted-average discount
rate of 12.00%.
The Company had cash payments for operating leases of $85,860 and
$43,612 for the years ended December 31, 2021 and 2020,
respectively.
The following table presents information about the amount, timing
and uncertainty of cash flows arising from the Company’s operating
leases as of December 31, 2021.
Maturity of Lease Liability
|
|
|
|
2022
|
|
|
86,881 |
|
2023
|
|
|
89,487 |
|
2024
|
|
|
30,121 |
|
Total undiscounted operating lease payments
|
|
$ |
206,489 |
|
Less: Imputed interest
|
|
|
27,436 |
|
Present value of operating lease liabilities
|
|
$ |
179,053 |
|
NOTE 8 – COMMITMENTS
On July 16, 2018, the Company entered into a consulting agreement
with a service provider that contains the following terms:
|
·
|
A $6,000 per month advance of Holy Cacao equity distribution will
be awarded every month Holy Cacao earns a net profit over a period
of twenty-four (24) consecutive months following the initial
product launch and production sale.
|
|
|
|
|
·
|
300,000 warrants for shares of the Company’s common stock will be
awarded after each of two consecutive twelve (12) month periods in
which Holy Cacao earns a net profit from gross annual product sales
of at least $1M. Each of the two 300,000 warrant awards will vest
equally over a twelve (12) month period. As of December 31, 2021,
these targets have not been achieved and the Company has determined
it is not probable of being met at this time, as such no
compensation was taken on them.
|
On August 14, 2019, the Company entered into an agreement with a
CFN Media. In consideration for the services and deliverables
provided by CFN Media, the Company will make three (3) cash
payments to CFN Media totaling $30,000. Payments will be made in
accordance with the following staged schedule:
“Stage 1” - $10,000 due upon the signing of the agreement for the
Stage 1 services and deliverables: the interview, lead generation
system and two (2) articles, including syndication, distribution
and placement. This payment has been made.
“Stage 2” - $10,000 due upon the Company’s receipt of CFN Media’s
invoice issued after CFN Media’s completion of Stage 1 and the
Company’s confirmation they are ready to continue with Stage 2,
which will include CFN Media’s delivery of two (2) Articles with
the embedded interview and lead generation, as well as syndication,
distribution and placement of services and deliverables.
“Stage 3” - $10,000 due upon the Company’s receipt of CFN Media’s
invoice issued after CFN Media’s completion of Stage 2 and the
Company’s confirmation they are ready to continue with Stage 3,
which will include CFN Media’s delivery of two (2) Articles with
the embedded interview and lead generation, as well as syndication,
distribution and placement of services and deliverables.
On October 10, 2019, the Company signed a master distribution
agreement with CBD Unlimited, Inc., which is a public company and a
master distributor, to distribute the Company’s hemp-based
chocolate products. The term of this agreement is four years. The
Company shall pay the distributor a commission for its services
hereunder amounting to applicable percentage of the sales price of
any sales or sales contract with a customer.
On January 14, 2020, the Company entered into an agreement with a
sales consultant to further the business purpose of the Company. In
consideration for the services provided by the consultant, the
Consultant shall be paid a fee of ten percent (10%) of each of the
consultant’s sales of the Company’s product.
On October 15, 2020, the Company entered into a chocolate sales
agreement with a sales consultant. The consultant will receive a
commission of the gross sales (net of returns) that were directly
generated by the consultant to new customers. The consultant shall
receive a sales commission of the gross sales (net of returns)
directly generated by the consultant to such distributor and such
distributor shall receive a commission of such gross sales (net of
returns). Commissions shall be paid within 30 days of the end of
the quarter in which they are deemed earned. No commissions are due
as of December 31, 2021. In addition, once the consultant has made
$75,000 of gross sales (net of returns) he shall receive 75,000
shares of the Company’s common stock. This agreement shall continue
for sixty months from the date of the agreement and will
automatically extend for additional successive sixty-month terms
unless written notice is delivered at least thirty days prior to
the end of the current term.
On November 9, 2020, the Company entered into an agreement with a
consultant. The consultant shall provide the following services:
develop a marketing plan and act as a sales agent with respect to
the wholesale of various products by the Company. As compensation
for the services, the consultant shall receive a cash payment in an
amount in excess of 9% of the profit margin. However, in the event
the average closing price of the Company’s common stock on the
common stock’s primary market over the final ten (10) trading days
of any month is greater than or equal to $0.50, then the cash
compensation for such month shall only be the amount of profit
margin generated by the sales of the products in excess of 14% of
gross sales and the amount of profit margin between 9% and 14% of
gross sales shall completely belong to the Company. Prior to the
payment date of each month, the consultant can elect to receive all
or part of the cash compensation due for such month in the form of
common stock by providing written notice of such election to the
Company. The number of shares to be issued shall be calculated
based upon a per share value equal to 80% of the valuation price.
This agreement shall commence on the effective date and shall
continue for a term of two (2) years. Prior to six months after the
effective date this agreement may not be cancelled without cause.
After six months this agreement may be sooner terminated by either
party upon sixty days written notice. Commencing 120 days after the
effective date, absent an effective registration statement by the
Company covering the shares, the sales consultant may “Put” to the
Company any vested shares at a price per share equal to the grant
price at any time during the term. The Company shall maintain a
separate account with funds to pay for the Put for as long as the
Put is exercisable and the Put right shall be subject to the terms
governing such account. As of December 31, 2021, the Company has
recorded a Put liability of $29,421. The Consultant has agreed to
lower the restricted cash amount for the Put to $5,900.
On November 9, 2020, the Company entered into a grant agreement
with a sales consultant. As compensation for the services, the
Company will issue up to three million (3,000,000) shares to the
sales consultant in monthly installments over the twenty (24) month
term of the agreement. The number of shares to be issued by the
Company to the sales consultant on a monthly basis will be
determined by the amount of net sales of various wholesale products
generated by the sales consultant at the end of each month
multiplied by a fixed percentage of nine percent (9%) divided by
the last closing market price of the shares as of the effective
date. In addition to the shares to be issued, the sales consultant
shall be issued three million (3,000,000) warrants to purchase
shares. One warrant shall be fully vested for every share issued.
The exercise price of each warrant shall be equal to the grant
price and each warrant shall be exercisable for thirty-six (36)
months following the date of vesting. Until such time as the shares
underlying the warrants are registered, the warrants may be
exercised via a cashless exercise. During the year ended December
31, 2021 the company issued 147,991 shares of common stock and
warrants with the right to purchase up to 57,275 shares of common
stock as compensation for services. As of December 31, 2021, there
were 2,852,009 shares of common stock and 2,942,725 warrants
remaining to be issued if certain performance thresholds are
met.
On January 14, 2021, the Company entered into an agreement with a
sales consultant to further the business purpose of the Company. In
consideration for the services provided by the consultant, the
consultant will receive a commission of the gross sales (net of
returns) that were directly generated by the consultant to new
customers. This agreement shall continue for sixty months from the
date of the agreement and will automatically extend for additional
successive sixty month terms unless written notice is delivered at
least thirty days prior to the end of the current term.
On July 13, 2021, the Company entered into an agreement with a
marketing consultant to further the business purpose of the
Company. In consideration for the services provided by the
consultant, the Consultant shall be paid a fee of $9,000, half of
which is to be paid in cash and half to be paid in common shares at
a 20% discount. The company issued the consultant 34,091 shares of
common stock at a fair market value of $4,500, using the stock
price of $0.13 per share, which represents a 20% discount to the
closing price on the day of issuance.
On July 13, 2021, the Company entered into an agreement with a
sales consultant to further the business purpose of the Company. In
consideration for the services provided by the consultant, the
Company will issue up to 240,000 shares of restricted common stock
of the Company based upon the consultant’s performance over a
six-month term. The shares will be issued each month if certain
milestones are met.
Commission costs for the year ended December 31, 2021 and 2020,
were $43,863 and $491, respectively. These expenses are included in
general and administrative expenses on the accompanying
consolidated statements of operations. As of December 31, 2021 and
2020, there were no accrued commissions outstanding.
NOTE 9 – CONCENTRATION RISKS
The Company recognizes the concentration of its merchant cash
advances, which could inherently create a potential risk to future
working capital in the event that the Company is not able to
collect all, or a majority, of the outstanding merchant cash
advances. The Company actively mitigates its portfolio
concentration risk by monitoring its merchant cash advance
provider’s ability to participate in merchant cash advances from
alternative providers and spreading merchant cash advance
participation across various merchants.
As of December 31, 2021, the Company’s receivables from merchant
cash advances included $29,290 from one merchant, representing 78%
of the Company’s merchant cash advances. The Company earned $22,368
of MCA income from one merchant, representing 56% of the Company’s
MCA income for the year ended December 31, 2021.
As of December 31, 2020, the Company’s receivables from merchant
cash advances included $59,719 from two merchants ($25,929 and
$33,790), representing 49% of the Company’s merchant cash advances.
The Company earned $84,525 and $27,175 of MCA income from two
merchants, representing 53.5% and 17%, respectively of the
Company’s MCA income for the twelve months ended December 31,
2020.
For the year ended December 31, 2021, the Company had sales
concentrations of 17%, 15% and 15% from three customers. There was
no sales concentration for the year ended December 31, 2020.
For the year ended December 31, 2021, the Company had purchase
concentrations of 79% from one vendor.
For the year ended December 31, 2020, the Company had purchase
concentrations of 49% and 14% from two vendors.
NOTE 10 – INCOME TAXES
There was no income tax expense reflected in the results of
operations for the years ended December 31, 2021 and 2020 because
the Company incurred a net loss in both years.
As of December 31, 2021, the Company had federal and state net
operating loss carry forwards of $7,287,000 and $5,155,000,
respectively, which may be used to offset future taxable income.
Approximately $1,222,000 will begin to expire in 2036 while
$6,065,000 will not expire but will be limited to 80% of
taxable income. The State NOL’s may be used indefinitely without
limitation.
The tax effects of temporary differences which give rise to
deferred tax assets (liabilities) are summarized as follows:
|
|
For the Years Ended December 31,
|
|
|
|
2021
|
|
|
2020
|
|
Net operating loss carry forwards
|
|
$ |
1,754,000 |
|
|
$ |
1,338,000 |
|
Stock based compensation
|
|
|
1,845,000 |
|
|
|
1,785,000 |
|
Fixed assets and intangibles
|
|
|
(47,000 |
) |
|
|
(60,000 |
) |
Allowance for Doubtful accounts
|
|
|
114,000 |
|
|
|
71,000 |
|
Accrued Expenses
|
|
|
78,000 |
|
|
|
10,000 |
|
Other carryforwards
|
|
|
8,000 |
|
|
|
7,000 |
|
Total deferred tax assets
|
|
$ |
3,752,000 |
|
|
$ |
3,151,000 |
|
|
|
|
|
|
|
|
|
|
Valuation allowance
|
|
|
(3,752,000 |
) |
|
|
(3,151,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
$ |
- |
|
|
$ |
- |
|
In assessing the realization of deferred tax assets, management
considers whether it is more likely than not that some portion or
all of the deferred tax assets will be realized. The ultimate
realization of deferred tax assets is dependent upon the generation
of future taxable income during the periods in which those
temporary differences become deductible. Deferred tax assets
consist primarily of the tax effect of NOL carry-forwards and stock
based compensation. The Company has provided a full valuation
allowance on the deferred tax assets because of the uncertainty
regarding its realizability.
Reconciliation of the statutory federal income tax to the Company's
effective tax:
|
|
For the year ended
|
|
|
|
December 31,
|
|
|
|
2021
|
|
|
2020
|
|
|
|
%
|
|
|
%
|
|
Statutory federal tax rate
|
|
|
21.00 |
% |
|
|
21.00 |
% |
State rate net of federal benefit
|
|
|
3.80 |
% |
|
|
3.97 |
% |
Permanent differences
|
|
|
(3.92 |
)% |
|
|
(0.74 |
)% |
Rate change
|
|
|
3.40 |
% |
|
-
|
%
|
Valuation allowance
|
|
|
(24.28 |
)% |
|
|
(24.23 |
)% |
|
|
|
|
|
|
|
|
|
Provision for income taxes
|
|
|
- |
% |
|
|
- |
% |
The Company’s policy is to record interest and penalties associated
with unrecognized tax benefits as additional income taxes in the
consolidated statements of operations. As of December 31, 2021 and
2020 the Company had no unrecognized tax benefits. There were no
changes in the Company’s unrecognized tax benefits during the years
ended December 31, 2021 and 2020. The Company did not recognize any
interest or penalties during the years ended December 31, 2021 and
2020 related to unrecognized tax benefits.
Tax years 2018-2021 remain open to examination for federal income
tax purposes and by other major taxing jurisdictions to which the
Company is subject.
NOTE 11 – SUBSEQUENT EVENTS
On January 4, 2022, the Company entered into a grant agreement with
a sales consultant. As compensation for the services, the Company
will issue up to 2,380,952 shares of restricted common stock to the
sales consultant in monthly installments over the twenty (24) month
term of the agreement. The number of shares to be issued by the
Company to the sales consultant on a monthly basis will be
determined by the amount of net sales of products generated by the
sales consultant at the end of each month multiplied by a fixed
percentage of 5% divided by the last closing market price of the
shares as of the effective date. Additionally, if the sales
consultant makes sales using salespeople who are not under contract
with the Company, the Company will pay the consultant a cash
commission at the end of each month equal to 5% of net sales over
the term.
On February 4, 2022, the Company issued a secured and guaranteed by
a Director, non-interest bearing promissory note of $30,000, which
matures on March 4, 2022. The loan has been extended to May 30,
2022 with the same terms and conditions.
On March 2, 2022, the Company entered into two agreements with two
consultants to further the business purpose of the Company. In
consideration for the services provided by the consultants, the
consultants will receive a 10% commission of the gross sales
(net of returns) that were directly generated by the consultants to
new customers. This agreement shall continue for sixty months from
the date of the agreement and will automatically extend for
additional successive sixty month terms unless written notice is
delivered at least thirty days prior to the end of the current
term.
On March 23, 2022, the Company entered into a grant agreement with
a sales consultant. As compensation for the services, the Company
will issue up to 2,083,333 shares of restricted common stock to the
sales consultant in monthly installments over the twenty (24) month
term of the agreement. The number of shares to be issued by the
Company to the sales consultant on a monthly basis will be
determined by the amount of net sales of products generated by the
sales consultant at the end of each month multiplied by a fixed
percentage of 5% divided by the last closing market price of the
shares as of the effective date.
On April 11, 2022, the Company entered into a binding memo of
understanding with a marketing consultant, who is National Football
League (NFL) celebrity. As compensation for the services, the
Company agrees to split the net profit on a 50 / 50 basis derived
from the sales of the Company’s products that will be branded under
the consultant’s name and result from the marketing consultant’s
efforts. The marketing consultant will be paid on a quarterly basis
over the two (2) year term.
Item 9. Changes in and Disagreements with
Accountants on Accounting and Financial
Disclosure.
Not applicable
Item 9A. Controls and
Procedures.
Conclusion Regarding the Effectiveness of Disclosure
Controls and Procedures
We maintain a set of disclosure controls and procedures designed to
ensure that information required to be disclosed by us in the
reports filed under the Securities Exchange Act, is recorded,
processed, summarized and reported within the time periods
specified by the SEC’s rules and forms. Disclosure controls are
also designed with the objective of ensuring that this information
is accumulated and communicated to our management, including our
chief executive officer and chief financial officer, as
appropriate, to allow timely decisions regarding required
disclosure. As further discussed below, we have identified material
weaknesses in the effectiveness, design and operation of our
disclosure controls and procedures.
Management’s Annual Report on Internal Control over
Financial Reporting
Our management is responsible for establishing and maintaining
adequate internal control over financial reporting. Internal
control over financial reporting is defined in Rule 13a-15(f) or
15d-15(f) promulgated under the Securities Exchange Act of 1934 as
a process designed by, or under the supervision of, the Company’s
principal executive officer and principal financial officer and
effected by our board of directors, management and other personnel,
to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for
external purposes in accordance with accounting principles
generally accepted in the United States (“U.S. GAAP”) and includes
those policies and procedures that:
1.
|
Pertain to the maintenance of records that in reasonable detail
accurately and fairly reflect the transactions and dispositions of
the assets of the Company;
|
2.
|
Provide reasonable assurance that transactions are recorded as
necessary to permit preparation of financial statements in
accordance with U.S. GAAP and that receipts and expenditures of the
Company are being made only in accordance with authorizations of
management and directors of the Company; and
|
3.
|
Provide reasonable assurance regarding prevention or timely
detection of unauthorized acquisition, use or disposition of the
Company’s assets that could have a material effect on the financial
statements.
|
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Projections of any evaluation of effectiveness to future periods
are subject to the risk that controls may become inadequate because
of changes in conditions, or that the degree of compliance with the
policies or procedures may deteriorate. All internal control
systems, no matter how well designed, have inherent limitations.
Therefore, even those systems determined to be effective can
provide only reasonable assurance with respect to financial
statement preparation and presentation. Because of the inherent
limitations of internal control, there is a risk that material
misstatements may not be prevented or detected on a timely basis by
internal control over financial reporting. However, these inherent
limitations are known features of the financial reporting process.
Therefore, it is possible to design into the process safeguards to
reduce, though not eliminate, this risk.
The Company’s management, including the chief executive officer and
chief financial officer, do not expect that its disclosure controls
or internal controls will prevent all error and all fraud. A
control system, no matter how well conceived and operated, can
provide only reasonable, not absolute, assurance that the
objectives of the control system are met. In addition, the design
of a control system must reflect the fact that there are resource
constraints, and the benefits of controls must be considered
relative to their costs. Because of the inherent limitations in all
control systems, no evaluation of controls can provide absolute
assurance that all control issues and instances of fraud, if any,
within a company have been detected. These inherent limitations
include the realities that judgments in decision-making can be
faulty, and that breakdowns can occur because of simple error or
mistake.
As of December 31, 2021, management has not completed an effective
assessment of the Company’s internal controls over financial
reporting based on the 2013 Committee of Sponsoring Organizations
(COSO) framework. Management has concluded that, during the period
covered by this report, our internal controls and procedures were
not effective to detect the inappropriate application of U.S. GAAP.
Management identified the following material weaknesses set forth
below in our internal control over financial reporting.
1. We lack the necessary corporate accounting resources to maintain
adequate segregation of duties.
2. We did not perform an effective risk assessment or monitor
internal controls over financial reporting or our cyber security
environment.
This annual report does not include an attestation report of the
Company’s registered public accounting firm regarding internal
control over financial reporting. Management’s report was not
subject to attestation by the Company’s registered public
accounting firm pursuant to rules of the SEC that permit the
Company to provide only the management’s report in this annual
report.
Item 9B. Other Information.
None
Item 9C. Disclosure Regarding Foreign
Jurisdictions that Prevent Inspections.
N/A
PART III
Item 10. Directors, Executive Officers and
Corporate Governance.
Identification of Directors and Executive
Officers:
As of April 14, 2022, our Board of Directors consisted of five
members. Each director holds office until his successor is duly
elected by the stockholders. The executive officers serve at the
pleasure of the Board of Directors. Our current directors and
executive officers are:
Name
|
|
Age
|
|
Position
|
|
Year Appointed
|
|
|
|
|
|
|
|
Harold Kestenbaum
|
|
72
|
|
Interim Chief Executive Officer and Chairman of the Board of
Directors
|
|
2017
|
Mark J. Keeley
|
|
59
|
|
Chief Financial Officer and Director
|
|
2017
|
Abraham Rosenblum
|
|
42
|
|
Secretary and Director
|
|
2016
|
Hershel Weiss
|
|
48
|
|
Director
|
|
2016
|
Michael Kaplan
|
|
54
|
|
Chief Marketing Officer and Director
|
|
2020
|
HAROLD L. KESTENBAUM is an attorney who has specialized in
franchise law and other matters relating to franchising since 1977.
From May 1982 until September 1986, Harold served as franchise and
general counsel to Sbarro, Inc., the national franchisor of over
1,000 family-style Italian restaurants, and was a director from
March 1985 to December 2006. From September 1983 to October 1989,
he served as President and Chairman of the Board of FranchiseIt
Corporation, the first publicly traded company specializing in
providing franchise marketing and consulting services and equity
financing to emerging franchise companies, which he co-founded.
Harold has authored the first book dedicated to the entrepreneur
who wants to franchise his/her business called “So You Want To
Franchise Your Business.” It is a step-by-step guide to what a
business person needs to know and do to properly roll out a
franchise program.
He has served as a Director of numerous nationally and
internationally known franchisors. He has been practicing franchise
law since 1981. He was with Gordon & Rees, a San Francisco
based national law firm, from September 2011 to June 2014. On May
1, 2019, he merged his practice with the Philadelphia based law
firm, Spadea and Lignana and is a partner in that firm.
Harold is a member of the American Bar Association’s Antitrust
Section, a member of the Antitrust Section’s Forum Committee on
Franchising since 1978, a member of the Subcommittee on Franchising
of the American Bar Association’s Corporation Banking and Business
Law Section, is a founding member and past Chairman of the New York
State Bar Association’s Franchise, Distribution and Licensing Law
Section, and he currently serves as Chairman for its Education and
Seminar Subcommittee (he has chaired Statewide seminar programs for
New York State attorneys in 1997, 2000, 2002, 2004 and 2005 and
chaired seminars on Franchise Law for the Nassau and Suffolk County
Bar Associations) and was a member of the International Franchise
Association’s Supplier Forum Advisory Board. He has published many
articles related to franchising and frequently lectures and appears
before numerous organizations and law schools speaking on various
topics in franchising. He has been chosen one of the top 100
franchise attorneys in North America by Franchise Times in
2004-2011 and was named one of the three best franchise attorneys
in the New York metro area by New York Magazine for 2005-2009 and
was named New York Super Lawyer as one of the Top Attorneys in the
New York Metro Area for 2007-2016.
Harold received his Bachelor of Arts Degree in 1971 from Queens
College, Queens, New York and earned his Juris Doctor Degree from
the University of Richmond School of Law, Richmond, Virginia, in
1975, where he was a member of Law Review.
MARK J. KEELEY is a Certified Public Accountant (CPA) who began his
career in public accounting with KPMG LLP in August 1985, after
graduating Summa Cum Laude from the University of Massachusetts
with a Bachelor’s Degree in Accounting and Computer Science. He
obtained a Master’s Degree in Finance from Boston College in May
1988 and continued his public accounting career at Coopers &
Lybrand LLP in September 1990 and was admitted to the Partnership
when Coopers & Lybrand LLP merged with Price Waterhouse LLP to
become PricewaterhouseCoopers LLP (PwC) in October 1988. He retired
from PwC in July 2014. From April 2015 through November 2016, he
served as the Chief Financial Officer (CFO) of Bradley, Foster
& Sargent, Inc.; a Registered Investment Advisor (RIA) and SEC
registrant with over $3B of assets under management.
Mr. Keeley is a qualified audit committee financial expert and one
of the first holders of the Certified Information Technology
Professional (CITP) designation granted by the American Institute
of Public Accountants (AICPA). He has applied his accounting,
financial management and information technology experience to a
broad range of national and international companies, including the
development of artificial intelligence (AI) solutions for the
restaurant and restaurant franchise industry.
He has regularly worked with the highest levels of senior
management, boards of directors, external auditors, investors, and
regulators to build consensus and reach a common understanding of
complex financial matters. He has testified to the United States
Congress regarding financial accounting and auditing aspects of the
U.S. Federal Government and served as PwC’s representative to
Congressman Mr. Michael Conaway.
ABRAHAM ROSENBLUM began his career in the automotive industry as a
distributor of wholesale parts, and eventually moved into owning
and developing real estate. Mr. Rosenblum has worked with “A rated”
tenants with several large corporations such as TD Bank, Walgreens
and Family Dollar. In 2007, Mr. Rosenblum began investing in real
estate along with institutional lenders. Mr. Rosenblum was the
President of a telecommunications carrier network, Tandem Transit,
which he helped form and finance for five years. Mr. Rosenblum was
educated at YTC in Brooklyn New York. He served on the Board of
Directors for several technology companies and automotive
distribution outlets. Mr. Rosenblum remains active in several
charitable organizations.
HERSHEL (HERSHY) WEISS is the Co-Founding Member of First Foods
Group Inc. Mr. Weiss has been active in the New Jersey, Connecticut
and Massachusetts real estate market for the last 21 years. As an
employee at Basad Management LLC and as a principal, Mr. Weiss has
been involved in residential, office, industrial and retail sectors
of the market, starting in maintenance, moving up to renovations
and construction, environmental remediation, then on to financing,
including complicated deal structures with lenders and investors
and finally acquisitions and redevelopment. Mr. Weiss actively
negotiates leases in the commercial and retail sectors and has
become very familiar with the retail food industry by working with
tenants starting out in the industry.
MICHAEL KAPLAN is a highly experienced marketing executive with
over three decades of enterprise retail and wholesale presence
amongst the world’s largest entities. He is a global sourcing
expert who has built merchandising programs on both private label
and licensed brands. He also has strong P&L management
experience coupled with skills in the areas of brand positioning,
marketing strategy, creative new product innovation, integrated
marketing communications and total product lifecycle management. He
has delivered aggressive revenue and earnings growth across
multiple retail and wholesale channels while following market
trends amongst retailers to compare data. He has led teams across
grocery, mass, drug, warehouse and specialty retailers throughout
North America, Europe and the Middle East and produced
multi-billion-dollar sales and royalties.
Penalties or
Sanctions
None of our directors or executive officers has been subject to any
penalties or sanctions imposed by a court relating to securities
legislation or by a securities regulatory authority or has entered
into a settlement agreement with a securities regulatory authority
or been subject to any other penalties or sanctions imposed by a
court or regulatory body that would likely be considered important
to a reasonable investor making an investment decision.
Personal
Bankruptcies
None of our directors or executive officers, nor any personal
holding company of any such person has, within the last ten years
become bankrupt, made a proposal under any legislation relating to
bankruptcy or insolvency, or been subject to or instituted any
proceedings, arrangement or compromise with creditors, or had a
receiver, receiver manager or trustee appointed to hold the assets
of that person.
Employment
Agreements
Executive Officer (“Interim CEO”). Mr. Kestenbaum earned $40,000
per year for his role as Chairman of the Board and no longer takes
compensation. As of December 31, 2021, the Company has accrued a
total of $40,000 of compensation for his role as Interim CEO under
a previous agreement.
On March 1, 2017, Mark J. Keeley assumed the role of Chief
Financial Officer (“CFO”). Pursuant to his Employment Agreement,
the CFO shall receive $20,833 per month. Additionally, Mr. Keeley
earns an additional $40,000 per year for his role as a Director of
the Board. On March 18, 2020, the Company issued its CFO and
Director warrants to purchase 500,000 shares of Series B Preferred
Stock in lieu of $250,000 of deferred salary (see Note 6). As of
December 31, 2021 and 2020, the Company has accrued $529,167 and
$329,167 in relation to the employment agreements and $24,203 and
$20,578 in relation to the payroll tax liability, respectively.
Family
Relationships
There are no family relationships between any of our directors or
executive officers and any other directors or executive
officers.
Term of
Office
All directors hold office for a one (1) year period and have been
duly elected and qualified. Directors will be elected at the annual
meetings to serve for one-year terms and until their successors are
duly elected and assume office. Each officer of the Company is
appointed by and serves at the discretion of the Board of
Directors. None of the officers or directors of the Company is
currently an officer or director of a company required to file
reports with the Securities and Exchange Commission, other than the
Company.
Involvement in
Certain Legal Proceedings
During the past five years, none of the following occurred with
respect to a present or former director, executive officer, or
employee: (1) any bankruptcy petition filed by or against any
business of which such person was a general partner or executive
officer either at the time of the bankruptcy or within two years
prior to that time; (2) any conviction in a criminal proceeding or
being subject to a pending criminal proceeding (excluding traffic
violations and other minor offences); (3) being subject to any
order, judgment or decree, not subsequently reversed, suspended or
vacated, of any court of competent jurisdiction, permanently or
temporarily enjoining, barring, suspending or otherwise limiting
his or her involvement in any type of business, securities or
banking activities; and (4) being found by a court of competent
jurisdiction (in a civil action), the SEC or the Commodities
Futures Trading Commission to have violated a federal or state
securities or commodities law, and the judgment has not been
reversed, suspended or vacated.
Board Committees
Audit
Committee
We do not have a separately-designated standing audit committee.
The Board of Directors performs the functions of an audit
committee, but no written charter governs the actions of the Board
of Directors when performing the functions that would generally be
performed by an audit committee. The Board of Directors approves
the selection of our independent accountants and meets and
interacts with the independent accountants to discuss issues
related to financial reporting. In addition, the Board of Directors
reviews the scope and results of the audit with the independent
accountants, reviews with management and the independent
accountants our annual operating results, considers the adequacy of
our internal accounting procedures and considers other auditing and
accounting matters, including fees to be paid to the independent
auditor and the performance of the independent auditor.
Compensation and
Nominations Committees
We currently have no compensation or nominating committee or other
board committee performing equivalent functions. Currently, the
members of our Board of Directors participate in discussions
concerning executive officer compensation and nominations to the
Board of Directors.
Shareholder
Communications
The Company does not have a process for security holders to send
communications to the board of directors due to the fact that
minimal securities are publicly traded.
Code of Conduct and Ethics
We have not adopted a Code of Ethics, as required by sections 406
and 407 of the Sarbanes-Oxley Act of 2002. Our management believes
that the size of our company and current operations at this time do
not require a code of ethics to govern the behavior of our
officers. We anticipate that we will adopt a code of ethics once we
are in a position to do so.
Item 11. Executive
Compensation.
On February 27, 2017, Harold Kestenbaum assumed the role of
Chairman of the Board of Directors and Interim Chief Executive
Officer (“Interim CEO”). Mr. Kestenbaum earned $40,000 per year for
his role as Chairman of the Board and no longer takes compensation.
As of December 31, 2021, the Company has accrued a total of $40,000
of compensation for his role as Interim CEO under a previous
agreement.
On March 1, 2017, Mark J. Keeley assumed the role of Chief
Financial Officer (“CFO”). Pursuant to his Employment Agreement,
the CFO shall receive $20,833 per month. Additionally, Mr. Keeley
earns an additional $40,000 per year for his role as a Director of
the Board. On March 18, 2020, the Company issued its CFO and
Director warrants to purchase 500,000 shares of Series B Preferred
Stock in lieu of $250,000 of deferred salary (see Note 6). As of
December 31, 2021 and 2020, the Company has accrued $529,167 and
$329,167 in relation to the employment agreements and $24,203 and
$20,578 in relation to the payroll tax liability, respectively.
Stock Option Plan
We do not have a stock option plan; however, we have issued
warrants to acquire our securities, as detailed in the notes to the
consolidated financial statements.
Employee Pension, Profit Sharing or Other Retirement
Plans
We do not have a defined benefit, pension plan, profit sharing or
other retirement plan, although we may adopt one or more of such
plans in the future.
Director’s Compensation
On May 10, 2018, the directors of the Company were awarded
share-based compensation for the service period of May 10, 2018
through December 31, 2021, as a one-time award of the ability to
purchase a particular amount of warrants, ranging from 80,000 to
400,000 (collectively the “Warrants”) with the following terms:
|
·
|
Number and Type – Each Director is entitled to a one-time award of
Warrants for the number of shares of Series B Preferred Stock of
the Company. Each share of Series B Preferred Stock shall have
voting rights equal to five (5) votes per share. Each share of
Series B Preferred Stock is convertible into five (5) shares of the
Company’s Common Stock (the “Common Stock”), including liquidation
preference over Common Stock.
|
|
|
|
|
·
|
Duration – The Warrants entitle each Director to purchase the
Series B Preferred Stock from the Company, after January 1, 2019
and before December 31, 2027.
|
|
|
|
|
·
|
Purchase Price - The purchase price is $0.60 per share of Series B
Preferred Stock.
|
|
|
|
|
·
|
Cashless Exercise - If on the date the Director surrenders all or a
portion of the Warrants for the purchase of Series B Preferred
Stock or the equivalent number of shares of Common Stock, the per
share market value of one share of Common Stock is greater than the
exercise price of the equivalent Warrant, in lieu of exercising the
Warrant by payment of cash, the Director may exercise the Warrant
by a cashless exercise and shall receive a ratably lower number of
shares of Series B Preferred Stock or the equivalent number of
shares of Common Stock.
|
|
|
|
|
·
|
Vesting - The Warrants are subject to a 32-month period whereby the
Warrants vest in equal monthly increments from May 10, 2018 through
December 31, 2021. Any unvested warrants are forfeited, if the
Director ceases to be a Director.
|
The Company issued warrants with respect to 1,280,000 Series B
Preferred Stock, in the aggregate. The Company expensed the fair
value of these warrants in the amount of $768,000 ratably during
the years ended December 31, 2018, 2019 and 2020. For the year
ended December 31, 2021 and 2020, the Company recorded $0 and
$290,981 as compensation expense related to the warrants,
respectively.
On February 26, 2019, the Company entered into director agreements
with each of the Directors of the Company. Pursuant to the
agreements, each Director may be compensated with share-based
and/or cash-based compensation. The Directors’ compensation for the
period January 1, 2019 through December 31, 2019 was $10,000 per
quarter per Director to be paid on a date determined by the Board
of Directors. In addition, the Directors were able to receive a
one-time award of the ability to purchase a particular amount of
warrants, as determined by the Board of Directors.
On January 1, 2020, the director agreements were renewed with the
same terms. As of December 31, 2021 and 2020 the Company has
accrued $380,000 and $320,000, respectively, in relation to the
director agreements.
On July 7, 2020, our Board of Directors appointed Michael Kaplan to
the Board of Directors.
Mr. Kaplan’s compensation as a director for the initial twelve
months will consist of one million (1,000,000) warrants which will
vest at the rate of 83,333 warrants per month for the initial
eleven months and the balance in the twelfth month, provided he is
a director on each vesting date, with the initial tranche vesting
on the day he takes office and then on each monthly anniversary of
such date thereafter. Each Warrant will be exercisable for 36
months after it vests and will be exercisable at a price of $0.18
per share. The warrants are valued at $177,200 based on the Black
Scholes Model.
Prior to Mr. Kaplan’s appointment to the Board of Directors, on
July 7, 2020 we entered into (i) a Subscription Agreement with Mr.
Kaplan to sell to him one million (1,000,000) shares of common
stock at a purchase price of $0.20 per share for a total purchase
price of $200,000, which shares shall be purchased in twelve (12)
equal monthly installments of 83,333 shares (the last installment
to cover 83,337 shares) with the initial purchase occurring on the
date thereof and subsequent installments on each monthly
anniversary thereafter (ii) a Consulting Agreement with Mr. Kaplan
to award him, as full compensation for two (2) years of service,
warrants to purchase two million (2,000,000) shares of common stock
at an exercise price of $0.18 per share, which was the closing
price of our common stock on such date. The warrants are valued at
$354,400 based on the Black Scholes Model; and (iii) an arrangement
with Mr. Kaplan that in the event he raises outside investment in
the Company in the amount of $500,000 - $2,000,000, he will receive
a warrant with one underlying share for each dollar he so raises.
As of December 31, 2021, $267,693 of the $354,000 has been
expensed.
The warrants shall vest upon the occurrence to the Company of
certain milestone events through the efforts of the consultant.
(See Note 6 in the notes to the consolidated financial
statements.)
If terminated with cause by the Company, the consultant shall not
thereafter be entitled to any form of compensation, the unvested
warrants shall terminate, and he shall be paid a buyout fee in the
amount of 250,000 fully vested warrants. If terminated without
cause by the Company, all unvested warrants shall be accelerated
and vest in one-half the time it was previously scheduled to
vest.
Related Party Transactions
Related party transactions are detailed in Note 2 in the notes to
the consolidated financial statements included elsewhere in this
Annual Report on Form 10-K.
The following table sets out the compensation received for the
years ended December 31, 2021 and 2020 with respect to each of the
individuals who served as the Company’s principal executive officer
and principal financial officer at any time during the last fiscal
year:
SUMMARY COMPENSATION TABLE
Name and Principal Position
|
|
Fiscal Year
|
|
Salary
|
|
|
Bonus
|
|
|
Stock
Awards
|
|
|
Option
Awards
|
|
|
Non-Equity Incentive Plan Compensation
|
|
|
Non-Qualified Deferred Plan Compensation
|
|
|
All
Other Compensation
|
|
|
Total
|
|
Mark J.
|
|
2021
|
|
$ |
250,000 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
250,000 |
|
Keeley
|
|
2020
|
|
$ (1)250,000 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
250,000 |
|
_____________
(1) On March 18, 2020, the Company issued the CFO and Director
warrants to purchase 500,000 shares of Series B Preferred Stock in
lieu of $250,000 of deferred salary. All remaining salary due was
accrued. No cash was issued.
Equity Compensation Plan Information - Employment
Agreements
Equity compensation issued in employment agreements in place on
December 31, 2021 and 2020 are detailed in Note 2 in the notes to
the consolidated financial statements included elsewhere in this
Annual Report on Form 10-K.
Outstanding Equity Awards at Fiscal Year-End
A summary of the Company’s outstanding warrant awards at fiscal
year end is as follows:
|
|
Number of
Securities
Underlying Unexercised
Options
Exercisable
(#)
|
|
|
Number of
Securities
Underlying Unexercised
Options
Unexercisable
(#)
|
|
|
Option
Exercise
Price
($)
|
|
|
Option
Expiration
Date
|
|
Number of
Shares or
Units
of Stock
that have not
Vested
(#)
|
|
|
Market
Value of
Shares or
Units of
Stock that
have not
Vested
(#)
|
|
Mark J. Keeley
|
|
|
1,950,000 |
|
|
|
- |
|
|
0.51 – 1.20
|
|
|
Various
|
|
|
- |
|
|
|
- |
|
Abraham Rosenblum
|
|
|
1,200,000 |
|
|
|
- |
|
|
0.51 – 1.20
|
|
|
Various
|
|
|
- |
|
|
|
- |
|
Hershel Weiss
|
|
|
1,200,000 |
|
|
|
- |
|
|
0.51 – 1.20
|
|
|
Various
|
|
|
- |
|
|
|
- |
|
Harold Kestenbaum
|
|
|
120,000 |
|
|
|
- |
|
|
0.51 – 1.20
|
|
|
Various
|
|
|
- |
|
|
|
- |
|
Michael Kaplan
|
|
|
1,100,000 |
|
|
|
1,900,000 |
|
|
|
0.18 |
|
|
July 26, 2024
|
|
|
- |
|
|
|
- |
|